Results for Chemical Groups
Chemical Group: Diesel Exhaust
- Measured in: Urine
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
6-OHNP | 1-Nitropyrene | pg/L^ | 109 | 110 | 89 | 130 | 60 | 120 | 200 | 660 | 90.8% | 9.4 pg/L |
8-OHNP | 1-Nitropyrene | pg/L^ | 149 | 88 | 76 | 100 | 51 | 91 | 160 | 400 | 87.2% | 11.4 pg/L |
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
6-OHNP | 1-Nitropyrene | pg/L^ | 142 | 150 | 120 | 180 | 83 | 150 | 300 | 960 | 88.7% | 13 pg/L |
8-OHNP | 1-Nitropyrene | pg/L^ | 155 | 89 | 76 | 100 | 49 | 78 | 160 | 410 | 76.1% | 22 pg/L |
Project: East Bay Diesel Exposure Project (EBDEP)
- Study Group: 80 East Bay residents (40 child-parent pairs)
- Sample Collection Date: -
- Study Group Subset: Children
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
6-OHNP | 1-Nitropyrene | pg/L^ | 40 | 150 | 110 | 200 | 63 | 170 | 330 | 1100 | 94.2% | 15.5 pg/L | § |
8-OHNP | 1-Nitropyrene | pg/L^ | 40 | 130 | 100 | 170 | 61 | 130 | 260 | 740 | 95.2% | 21.2 pg/L | ♢ |
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
6-OHNP | 1-Nitropyrene | pg/L^ | 38 | 240 | 180 | 310 | 130 | 240 | 540 | 1500 | 97.8% | 15.5 pg/L | † Δ |
8-OHNP | 1-Nitropyrene | pg/L^ | 40 | 150 | 120 | 190 | 82 | 160 | 290 | 730 | 94.7% | 21.2 pg/L | ‡ |
Chemical Group: Environmental Phenols
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 109 | 24.4 | 16.0 | 37.2 | 5.70 | 22.8 | 86.7 | 797 | 94.5% | 0.500 µg/L |
BPA | Bisphenol A | µg/L | 109 | 1.40 | 1.08 | 1.80 | 0.660 | 1.31 | 2.82 | 13.3 | 89.9% | 0.200 µg/L |
Butyl paraben | Butyl Paraben | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 13.5 | 21.1% | 0.500 µg/L |
Ethyl paraben | Ethyl Paraben | µg/L | 109 | * | * | * | <LOD | <LOD | 6.83 | 127 | 44.0% | 0.500 µg/L |
Methyl paraben | Methyl Paraben | µg/L | 105 | 78.4 | 56.2 | 109 | 21.7 | 76.4 | 282 | 1,060 | 99.0% | 0.500 µg/L |
Propyl paraben | Propyl Paraben | µg/L | 109 | 7.66 | 4.89 | 12.0 | 0.555 | 8.38 | 49.1 | 367 | 75.2% | 0.500 µg/L |
Triclosan | Triclosan | µg/L | 109 | 11.7 | 7.77 | 17.5 | 2.54 | 9.29 | 44.3 | 702 | 96.3% | 0.200 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 218 | 76.7 | 43.4 | 135 | 10.9 | 76.2 | 431 | 6720 | 95.8% | 1.00 µg/L | ● |
Benzophenone-3 | Benzophenone-3 | µg/g creatinine | 218 | 83.8 | 49.1 | 143 | 11.8 | 70.8 | 408 | 3520 | 95.8% | 1.00 µg/L | ● |
BPA | Bisphenol A | µg/L | 218 | 1.33 | 1.05 | 1.69 | 0.648 | 1.52 | 3.56 | 5.66 | 97.4% | 0.100 µg/L | ● |
BPA | Bisphenol A | µg/g creatinine | 218 | 1.46 | 1.20 | 1.77 | 0.786 | 1.53 | 2.39 | 5.58 | 97.4% | 0.100 µg/L | ● |
Butyl paraben | Butyl paraben | µg/L | 218 | * | * | * | <LOD | <LOD | 0.456 | 20.5 | 33.4% | 0.200 µg/L | ● |
Butyl paraben | Butyl paraben | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.834 | 21.2 | 33.4% | 0.200 µg/L | ● |
Ethyl paraben | Ethyl paraben | µg/L | 218 | * | * | * | <LOD | <LOD | 10.0 | 168 | 47.8% | 1.00 µg/L | ● |
Ethyl paraben | Ethyl paraben | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 11.7 | 161 | 47.8% | 1.00 µg/L | ● |
Methyl paraben | Methyl paraben | µg/L | 218 | 62.9 | 41.3 | 95.9 | 21.1 | 75.4 | 241 | 906 | 94.3% | 1.00 µg/L | ● |
Methyl paraben | Methyl paraben | µg/g creatinine | 218 | 68.8 | 47.6 | 99.6 | 23.5 | 83.8 | 237 | 924 | 94.3% | 1.00 µg/L | ● |
Propyl paraben | Propyl paraben | µg/L | 218 | 9.58 | 5.98 | 15.4 | <LOD | 9.05 | 55.5 | 325 | 71.5% | 1.00 µg/L | ● |
Propyl paraben | Propyl paraben | µg/g creatinine | 218 | 10.48 | 6.68 | 16.4 | <LOD | 9.51 | 70.2 | 287 | 71.5% | 1.00 µg/L | ● |
Triclosan | Triclosan | µg/L | 218 | 11.9 | 7.34 | 19.4 | 2.25 | 9.09 | 60.4 | 801 | 98.5% | 0.100 µg/L | ● |
Triclosan | Triclosan | µg/g creatinine | 218 | 13.1 | 8.00 | 21.3 | 2.31 | 11.3 | 54.2 | 812 | 98.5% | 0.100 µg/L | ● |
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
- Study Group Subset: Women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 60 | 31.6 | 18.4 | 54.2 | 7.52 | 22.3 | 152 | 513 | 95.0% | 1.00 |
BPA | Bisphenol A | µg/L | 60 | * | * | * | <LOD | <LOD | 0.756 | 1.96 | 46.7% | 0.100 |
BPF | Bisphenol F | µg/L | 60 | * | * | * | <LOD | <LOD | <LOD | 0.862 | 23.3% | 0.200 |
BPS | Bisphenol S | µg/L | 60 | 0.382 | 0.269 | 0.544 | 0.106 | 0.342 | 1.33 | 2.42 | 76.7% | 0.100 |
Butyl paraben | Butyl paraben | µg/L | 60 | * | * | * | <LOD | <LOD | <LOD | 0.885 | 16.7% | 0.100 |
Ethyl paraben | Ethyl paraben | µg/L | 60 | * | * | * | <LOD | <LOD | 3.51 | 71.4 | 35.0% | 0.500 |
Methyl paraben | Methyl paraben | µg/L | 60 | 15.7 | 9.39 | 26.2 | 4.23 | 12.7 | 60.1 | 291 | 95.0% | 0.500 |
Propyl paraben | Propyl paraben | µg/L | 60 | 2.10 | 1.11 | 3.97 | <LOD | 2.57 | 9.28 | 81.3 | 66.7% | 0.200 |
Triclocarban | Triclocarban | µg/L | 60 | * | * | * | <LOD | <LOD | <LOD | 0.211 | 16.7% | 0.100 |
Triclosan | Triclosan | µg/L | 60 | 1.67 | 0.887 | 3.15 | 0.237 | 0.908 | 8.27 | 103 | 81.7% | 0.200 |
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 151 | 18.5 | 13.7 | 25.1 | 5.59 | 18.0 | 50.0 | 493 | 96.0% | 1.00 |
BPA | Bisphenol A | µg/L | 151 | 0.503 | 0.419 | 0.603 | <LOD | 0.466 | 1.12 | 3.19 | 69.5% | 0.200 |
BPS | Bisphenol S | µg/L | 151 | * | * | * | <LOD | 0.233 | 0.593 | 2.25 | 64.9% | 0.100 |
Ethyl paraben | Ethyl paraben | µg/L | 151 | * | * | * | <LOD | <LOD | 2.02 | 69.7 | 35.8% | 0.500 |
Methyl paraben | Methyl paraben | µg/L | 151 | 15.3 | 10.9 | 21.5 | 3.11 | 12.6 | 79.4 | 535 | 94.0% | 0.500 |
Propyl paraben | Propyl paraben | µg/L | 151 | * | * | * | <LOD | 1.54 | 14.8 | 223 | 60.3% | 0.200 |
Triclocarban | Triclocarban | µg/L | 151 | * | * | * | <LOD | <LOD | <LOD | 0.307 | 11.3% | 0.100 |
Triclosan | Triclosan | µg/L | 151 | * | * | * | <LOD | <LOD | 3.02 | 389 | 45.0% | 1.00 |
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 90 | 14.4 | 9.16 | 22.6 | 3.70 | 13.1 | 47.4 | 190 | 90.0% | 0.500 µg/L | ⌂ |
BPA | Bisphenol A | µg/L | 90 | 0.287 | 0.233 | 0.352 | 0.124 | 0.281 | 0.598 | 0.895 | 82.2% | 0.100 µg/L | ⌂ |
BPF | Bisphenol F | µg/L | 90 | * | * | * | <LOD | <LOD | 0.573 | 2.03 | 41.1% | 0.200 µg/L | ⌂ |
BPS | Bisphenol S | µg/L | 90 | * | * | * | <LOD | 0.288 | 0.875 | 2.85 | 64.4% | 0.100 µg/L | ⌂ |
Butyl paraben | Butyl paraben | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.114 | 11.1% | 0.100 µg/L | ⌂ |
Ethyl paraben | Ethyl paraben | µg/L | 90 | * | * | * | <LOD | <LOD | 0.212 | 8.92 | 25.6% | 0.200 µg/L | ⌂ |
Methyl paraben | Methyl paraben | µg/L | 90 | 8.33 | 5.15 | 13.5 | 1.01 | 9.57 | 57.1 | 152 | 80.0% | 0.500 µg/L | ⌂ |
Propyl paraben | Propyl paraben | µg/L | 90 | * | * | * | <LOD | <LOD | 13.5 | 42.5 | 50.0% | 0.200 µg/L | ⌂ |
Triclocarban | Triclocarban | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.6% | 0.100 µg/L | ⌂ |
Triclosan | Triclosan | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 1.82 | 18.9% | 1.00 µg/L | ⌂ |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Benzophenone-3 | Benzophenone-3 | µg/L | 101 | 78.5 | 58.3 | 106 | 27.0 | 79.3 | 186 | 867 | 100% | 1.00 |
BPA | Bisphenol A | µg/L | 101 | 1.58 | 1.25 | 1.99 | 0.718 | 1.53 | 3.16 | 11.9 | 94.1% | 0.20 |
Butyl paraben | Butyl paraben | µg/L | 101 | * | * | * | <LOD | <LOD | 0.68 | 5.9 | 44.6% | 0.50 |
Ethyl paraben | Ethyl paraben | µg/L | 101 | * | * | * | <LOD | <LOD | 2.52 | 56.5 | 35.6% | 1.0 |
Methyl paraben | Methyl paraben | μg/L | 101 | 46.9 | 34.2 | 64.3 | 19.6 | 48.0 | 108 | 687 | 98.0% | 1.0 |
Propyl paraben | Propyl paraben | μg/L | 101 | * | * | * | <LOD | 2.96 | 19.0 | 135 | 61.4% | 1.0 |
Triclosan | Triclosan | μg/L | 101 | 20.2 | 13.5 | 30.2 | 3.00 | 19.6 | 103 | 563 | 99.0% | 0.50 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
Benzophenone-3 | Benzophenone-3 | μg/L | 89 | 33.0 | 20.5 | 53.2 | 8.41 | 26.6 | 124 | 1320 | 0.50 |
BPA | Bisphenol A | μg/L | 89 | 1.25 | 0.984 | 1.58 | 0.490 | 1.27 | 3.13 | 4.85 | 0.20 |
Triclosan | Triclosan | μg/L | 89 | 17.2 | 10.5 | 28.2 | 2.44 | 11.1 | 139 | 445 | 1.0 |
Chemical Group: Herbicides
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
2,4-D | 2_4-D | µg/L | 109 | 0.304 | 0.245 | 0.376 | 0.163 | 0.340 | 0.617 | 1.92 | 90.8% | 0.0500 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
2,4-D | 2,4-D | µg/L | 218 | 0.173 | 0.137 | 0.217 | 0.0807 | 0.159 | 0.302 | 1.29 | 81.9% | 0.0500 µg/L | ● |
2,4-D | 2,4-D | µg/g creatinine | 218 | 0.189 | 0.153 | 0.233 | 0.113 | 0.185 | 0.323 | 1.61 | 81.9% | 0.0500 µg/L | ● |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
2,4-D | 2,4-D | μg/L | 101 | 0.27 | 0.21 | 0.34 | 0.13 | 0.28 | 0.51 | 1.46 | 90.1% | 0.050 |
2,4,5-T | 2,4,5-T | μg/L | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.050 |
Chemical Group: Metals
- Measured in: Blood
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 1
- Study Group: 100 Chinese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
Cadmium | Cadmium | µg/L | 96 | 0.524 | 0.462 | 0.595 | 0.344 | 0.520 | 0.801 | 1.15 | 99% | 0.150 |
Lead | Lead | µg/dL | 96 | 1.23 | 1.11 | 1.37 | 0.843 | 1.23 | 1.90 | 2.37 | 100% | 0.0500 |
Mercury | Mercury | µg/L | 96 | 3.58 | 3.01 | 4.26 | 2.47 | 4.12 | 7.13 | 9.24 | 100% | 0.150 |
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 2
- Study Group: 100 Vietnamese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
Cadmium | Cadmium | µg/L | 99 | 0.592 | 0.526 | 0.666 | 0.374 | 0.609 | 0.892 | 1.29 | 100% | 0.0750 |
Lead | Lead | µg/dL | 99 | 1.12 | 1.02 | 1.22 | 0.858 | 1.06 | 1.41 | 2.07 | 100% | 0.0250 |
Mercury | Mercury | µg/L | 99 | 4.77 | 4.13 | 5.51 | 3.22 | 5.18 | 8.04 | 9.99 | 100% | 0.0750 |
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Cadmium | Cadmium | µg/L | 110 | 0.271 | 0.237 | 0.311 | 0.170 | 0.275 | 0.390 | 0.990 | 100% | 0.06 µg/L |
Lead | Lead | µg/dL | 110 | 1.05 | 0.931 | 1.18 | 0.700 | 1.05 | 1.47 | 2.45 | 100% | 0.02 µg/dL |
Manganese | Manganese | µg/L | 110 | 8.09 | 7.62 | 8.58 | 6.50 | 8.40 | 9.80 | 13.4 | 100% | 0.45 µg/L |
Mercury | Mercury | µg/L | 110 | 0.748 | 0.602 | 0.929 | 0.370 | 0.745 | 1.79 | 4.26 | 99.1% | 0.04 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Cadmium | Cadmium | µg/L | 315 | 0.247 | 0.220 | 0.277 | 0.161 | 0.227 | 0.380 | 0.939 | 100% | 0.0111 µg/L | □ |
Lead | Lead | µg/dL | 315 | 0.749 | 0.664 | 0.846 | 0.416 | 0.703 | 1.31 | 2.43 | 100% | 0.0109 µg/dL | □ |
Manganese | Manganese | µg/L | 315 | 9.17 | 8.76 | 9.60 | 7.63 | 9.08 | 10.8 | 15.7 | 100% | 1.00 µg/L | □ |
Mercury | Mercury | µg/L | 315 | 0.677 | 0.573 | 0.799 | 0.339 | 0.693 | 1.26 | 3.52 | 99.9% | 0.0294 µg/L | □ |
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Cadmium | Cadmium | µg/L | 425 | 0.258 | 0.232 | 0.286 | 0.173 | 0.248 | 0.357 | 0.785 | 99.6% | 0.0750 µg/L | ▶ |
Lead | Lead | µg/dL | 425 | 0.768 | 0.683 | 0.862 | 0.480 | 0.730 | 1.26 | 2.32 | 100% | 0.0250 µg/dL | ▶ |
Manganese | Manganese | µg/L | 425 | 10.6 | 10.1 | 11.2 | 8.38 | 10.4 | 12.6 | 20.3 | 100% | 0.750 µg/L | ▶ |
Mercury | Mercury | µg/L | 425 | 0.975 | 0.794 | 1.20 | 0.387 | 1.04 | 2.56 | 6.02 | 92.9% | 0.125 µg/L | ▶ |
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Cadmium | Cadmium | µg/L | 359 | 0.275 | 0.246 | 0.307 | 0.161 | 0.266 | 0.478 | 0.793 | 99.1% | 0.0750 µg/L | ◁ |
Lead | Lead | µg/dL | 359 | 0.661 | 0.591 | 0.739 | 0.417 | 0.712 | 1.08 | 1.80 | 100% | 0.0250 µg/dL | ◁ |
Manganese | Manganese | µg/L | 359 | 10.1 | 9.71 | 10.6 | 8.03 | 9.96 | 12.3 | 15.9 | 100% | 0.250 µg/L | ◁ |
Mercury | Mercury | µg/L | 359 | 0.719 | 0.581 | 0.889 | 0.279 | 0.778 | 1.51 | 6.12 | 94.8% | 0.0750 µg/L | ◁ |
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
Cadmium | Cadmium | µg/L | 88 | 0.279 | 0.235 | 0.332 | 0.156 | 0.289 | 0.48 | 0.629 | 95.5% | 0.0750 µg/L | ⌂ |
Lead | Lead | µg/dL | 88 | 0.690 | 0.606 | 0.785 | 0.474 | 0.706 | 0.900 | 1.42 | 100% | 0.0250 µg/dL | ⌂ |
Manganese | Manganese | µg/L | 88 | 9.13 | 8.46 | 9.87 | 7.12 | 9.54 | 11.9 | 14.1 | 100% | 0.250 µg/L | ⌂ |
Mercury | Mercury | µg/L | 88 | 1.03 | 0.809 | 1.30 | 0.500 | 1.16 | 2.34 | 4.04 | 98.7% | 0.0750 µg/L | ⌂ |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of detection (LOD) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Cadmium | Cadmium | μg/L | 101 | 0.19 | 0.18 | 0.21 | 0.15 | 0.20 | 0.24 | 0.35 | 78.2% | 0.15 |
Lead | Lead | μg/dL | 101 | 0.957 | 0.872 | 1.05 | 0.690 | 0.950 | 1.22 | 2.01 | 100% | 0.02 |
Manganese | Manganese | μg/L | 101 | 7.61 | 7.26 | 7.98 | 6.50 | 7.70 | 8.79 | 11.4 | 100% | 0.54 |
Mercury | Mercury | μg/L | 101 | 2.79 | 2.36 | 3.30 | 1.82 | 2.90 | 5.48 | 9.79 | 100% | 0.06 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
Cadmium | Cadmium | μg/L | 77 | 0.22 | 0.19 | 0.24 | 0.16 | 0.22 | 0.31 | 0.38 | 0.14 and 0.15** |
Lead | Lead | μg/dL | 77 | 0.65 | 0.57 | 0.75 | 0.45 | 0.60 | 0.84 | 1.6 | 0.027 |
Mercury | Mercury | μg/L | 77 | 0.45 | 0.37 | 0.54 | 0.26 | 0.46 | 0.76 | 1.1 | 0.064 |
Chemical Group: Metals
- Measured in: Urine
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 1
- Study Group: 100 Chinese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Arsenic | Arsenic | µg/L | 100 | 22.2 | 18.2 | 27.0 | 12.6 | 22.1 | 44.0 | 131 | 100% | 0.162 |
Cadmium | Cadmium | µg/g creatinine | 100 | 0.450 | 0.377 | 0.536 | 0.222 | 0.460 | 0.913 | 1.75 | 97% | 0.0391 µg/L |
Mercury | Mercury | µg/L | 100 | 0.301 | 0.246 | 0.367 | 0.135 | 0.301 | 0.599 | 1.71 | 99% | 0.0300 |
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 2
- Study Group: 100 Vietnamese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Arsenic | Arsenic | µg/L | 100 | 33.6 | 27.4 | 41.1 | 18.0 | 35.4 | 70.5 | 121 | 100% | 0.100 |
Cadmium | Cadmium | µg/g | 100 | 0.625 | 0.527 | 0.740 | 0.353 | 0.712 | 1.12 | 2.16 | 99% | 0.0300 µg/L |
Mercury | Mercury | µg/L | 100 | 0.432 | 0.349 | 0.535 | 0.218 | 0.418 | 0.816 | 2.11 | 97% | 0.0500 |
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Arsenic | Arsenic | µg/L | 108 | 11.6 | 9.30 | 14.5 | 5.08 | 10.9 | 21.5 | 102 | 100% | 0.0493 µg/L |
Cadmium | Cadmium | µg/g creatinine | 108 | 0.301 | 0.267 | 0.339 | 0.186 | 0.300 | 0.461 | 0.853 | 100% | 0.0420 µg/L |
Mercury | Mercury | µg/L | 108 | 0.210 | 0.168 | 0.263 | 0.087 | 0.217 | 0.509 | 1.14 | 98.1% | 0.0163 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Arsenic | Arsenic | µg/L | 218 | 8.60 | 7.05 | 10.5 | 5.08 | 10.3 | 14.0 | 41.6 | 100% | 0.0493 µg/L | ● |
Arsenic | Arsenic | µg/g creatinine | 218 | 9.40 | 8.25 | 10.71 | 5.35 | 9.29 | 13.8 | 29 | 100% | 0.0493 µg/L | ● |
Cadmium | Cadmium | µg/L | 218 | 0.184 | 0.145 | 0.235 | 0.0932 | 0.173 | 0.412 | 1.02 | 87.8% | 0.0420 µg/L | ● |
Cadmium | Cadmium | µg/g creatinine | 218 | 0.202 | 0.166 | 0.245 | 0.111 | 0.193 | 0.334 | 0.928 | 87.8% | 0.0420 µg/L | ● |
Cobalt | Cobalt | µg/L | 218 | 0.190 | 0.146 | 0.247 | 0.0872 | 0.181 | 0.417 | 1.24 | 98.5% | 0.0113 µg/L | ● |
Cobalt | Cobalt | µg/g creatinine | 218 | 0.207 | 0.168 | 0.256 | 0.113 | 0.166 | 0.305 | 1.36 | 98.5% | 0.0113 µg/L | ● |
Manganese | Manganese | µg/L | 218 | * | * | * | <LOD | 0.0555 | 0.106 | 0.461 | 56.3% | 0.0449 µg/L | ● |
Manganese | Manganese | µg/g creatinine | 218 | * | * | * | <LOD | 0.0632 | 0.123 | 0.89 | 56.3% | 0.0449 µg/L | ● |
Mercury | Mercury | µg/L | 218 | 0.148 | 0.114 | 0.194 | 0.0766 | 0.154 | 0.358 | 1.09 | 93.9% | 0.0163 µg/L | ● |
Mercury | Mercury | µg/g creatinine | 218 | 0.162 | 0.130 | 0.202 | 0.0756 | 0.182 | 0.314 | 0.811 | 93.9% | 0.0163 µg/L | ● |
Molybdenum | Molybdenum | µg/L | 218 | 40.4 | 31.8 | 51.4 | 20.0 | 48.6 | 81.1 | 202 | 100% | 0.0736 µg/L | ● |
Molybdenum | Molybdenum | µg/g creatinine | 218 | 44.2 | 36.9 | 52.9 | 28.8 | 40.2 | 71.0 | 158 | 100% | 0.0736 µg/L | ● |
Thallium | Thallium | µg/L | 218 | 0.164 | 0.136 | 0.197 | 0.125 | 0.182 | 0.296 | 0.373 | 98.4% | 0.00982 µg/L | ● |
Thallium | Thallium | µg/g creatinine | 218 | 0.179 | 0.161 | 0.198 | 0.135 | 0.180 | 0.247 | 0.392 | 98.4% | 0.00982 µg/L | ● |
Tungsten | Tungsten | µg/L | 218 | 0.0762 | 0.0584 | 0.0994 | 0.0447 | 0.0924 | 0.155 | 0.333 | 95.8% | 0.00493 µg/L | ● |
Tungsten | Tungsten | µg/g creatinine | 218 | 0.0833 | 0.0684 | 0.101 | 0.0475 | 0.0812 | 0.141 | 0.399 | 95.8% | 0.00493 µg/L | ● |
Uranium | Uranium | µg/L | 218 | 0.00709 | 0.00533 | 0.00944 | 0.00215 | 0.00752 | 0.0181 | 0.0635 | 82.0% | 0.00134 µg/L | ● |
Uranium | Uranium | µg/g creatinine | 218 | 0.00775 | 0.00606 | 0.00990 | 0.00349 | 0.00664 | 0.0149 | 0.0645 | 82.0% | 0.00134 µg/L | ● |
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Antimony | Antimony | µg/L | 428 | * | * | * | < LOD | < LOD | 0.0316 | 0.101 | 26.2% | 0.0300 µg/L | ▼ |
Antimony | Antimony | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | 0.0676 | 0.180 | 26.6% | 0.0300 µg/L | ▷ |
Arsenic | Arsenic | µg/L | 428 | 8.06 | 6.69 | 9.71 | 3.63 | 7.91 | 16.7 | 67.2 | 100% | 0.100 µg/L | ▼ |
Arsenic | Arsenic | µg/g creatinine | 426 | 10.6 | 9.06 | 12.3 | 5.16 | 9.14 | 18.8 | 59.7 | 100% | 0.100 µg/L | ▷ |
Cadmium | Cadmium | µg/L | 428 | 0.153 | 0.130 | 0.182 | 0.0707 | 0.169 | 0.342 | 0.743 | 100% | 0.0100 µg/L | ▼ |
Cadmium | Cadmium | µg/g creatinine | 426 | 0.199 | 0.175 | 0.227 | 0.115 | 0.187 | 0.338 | 0.691 | 100% | 0.0100 µg/L | ▷ |
Cobalt | Cobalt | µg/L | 428 | 0.217 | 0.184 | 0.256 | 0.119 | 0.210 | 0.398 | 1.37 | 100% | 0.0100 µg/L | ▼ |
Cobalt | Cobalt | µg/g creatinine | 426 | 0.284 | 0.251 | 0.321 | 0.154 | 0.262 | 0.528 | 1.18 | 100% | 0.0100 µg/L | ▷ |
Manganese | Manganese | µg/L | 428 | * | * | * | < LOD | < LOD | < LOD | 0.174 | 15.2% | 0.100 µg/L | ▼ |
Manganese | Manganese | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | < LOD | 0.611 | 15.4% | 0.100 µg/L | ▷ |
Mercury | Mercury | µg/L | 428 | 0.202 | 0.159 | 0.256 | 0.0814 | 0.232 | 0.519 | 2.63 | 97.1% | 0.0100 µg/L | ▼ |
Mercury | Mercury | µg/g creatinine | 426 | 0.262 | 0.218 | 0.314 | 0.143 | 0.277 | 0.516 | 1.73 | 97.3% | 0.0100 µg/L | ▷ |
Molybdenum | Molybdenum | µg/L | 428 | 36.0 | 30.5 | 42.5 | 20.0 | 39.6 | 79.2 | 160 | 100% | 0.300 µg/L | ▼ |
Molybdenum | Molybdenum | µg/g creatinine | 426 | 47.1 | 41.7 | 53.2 | 28.5 | 44.9 | 79.7 | 194 | 100% | 0.300 µg/L | ▷ |
Thallium | Thallium | µg/L | 428 | 0.154 | 0.134 | 0.178 | 0.0850 | 0.169 | 0.305 | 0.527 | 99.8% | 0.0100 µg/L | ▼ |
Thallium | Thallium | µg/g creatinine | 426 | 0.200 | 0.183 | 0.218 | 0.132 | 0.197 | 0.284 | 0.491 | 100% | 0.0100 µg/L | ▷ |
Uranium | Uranium | µg/L | 428 | * | * | * | < LOD | < LOD | 0.0193 | 0.116 | 48.6% | 0.0100 µg/L | ▼ |
Uranium | Uranium | µg/g creatinine | 426 | * | * | * | < LOD | < LOD | 0.0313 | 0.116 | 49.3% | 0.0100 µg/L | ▷ |
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Antimony | Antimony | µg/L | 357 | * | * | * | < LOD | < LOD | < LOD | 0.343 | 19.2% | 0.0500 µg/L | ▽ |
Antimony | Antimony | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | < LOD | 0.309 | 19.2% | 0.0500 µg/L | ▽ |
Arsenic | Arsenic | µg/L | 357 | 6.40 | 5.16 | 7.96 | 2.69 | 6.27 | 11.5 | 42.1 | 100% | 0.100 µg/L | ▽ |
Arsenic | Arsenic | µg/g creatinine | 357 | 8.40 | 7.10 | 9.94 | 4.02 | 6.86 | 14.2 | 50.4 | 100% | 0.100 µg/L | ▽ |
Cadmium | Cadmium | µg/L | 357 | 0.172 | 0.145 | 0.205 | 0.0786 | 0.186 | 0.363 | 0.901 | 95.1% | 0.0300 µg/L | ▽ |
Cadmium | Cadmium | µg/g creatinine | 357 | 0.226 | 0.195 | 0.262 | 0.112 | 0.227 | 0.394 | 1.05 | 95.1% | 0.0300 µg/L | ▽ |
Cobalt | Cobalt | µg/L | 357 | 0.182 | 0.154 | 0.215 | 0.0927 | 0.200 | 0.360 | 1.05 | 92.9% | 0.0300 µg/L | ▽ |
Cobalt | Cobalt | µg/g creatinine | 357 | 0.238 | 0.209 | 0.272 | 0.125 | 0.200 | 0.390 | 1.11 | 92.9% | 0.0300 µg/L | ▽ |
Manganese | Manganese | µg/L | 357 | * | * | * | < LOD | < LOD | < LOD | 0.212 | 15.4% | 0.100 µg/L | ▽ |
Manganese | Manganese | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | < LOD | 0.555 | 15.4% | 0.100 µg/L | ▽ |
Mercury | Mercury | µg/L | 357 | 0.165 | 0.138 | 0.197 | 0.0706 | 0.168 | 0.362 | 0.922 | 91.6% | 0.0300 µg/L | ▽ |
Mercury | Mercury | µg/g creatinine | 357 | 0.216 | 0.184 | 0.254 | 0.104 | 0.213 | 0.402 | 1.34 | 91.6% | 0.0300 µg/L | ▽ |
Molybdenum | Molybdenum | µg/L | 357 | 33.5 | 28.2 | 39.8 | 18.6 | 35.6 | 64.7 | 168 | 100% | 0.300 µg/L | ▽ |
Molybdenum | Molybdenum | µg/g creatinine | 357 | 43.9 | 38.8 | 49.7 | 29.3 | 42.9 | 62.9 | 161 | 100% | 0.300 µg/L | ▽ |
Thallium | Thallium | µg/L | 357 | 0.148 | 0.130 | 0.169 | 0.0884 | 0.158 | 0.257 | 0.472 | >99.9% | 0.0100 µg/L | ▽ |
Thallium | Thallium | µg/g creatinine | 357 | 0.194 | 0.177 | 0.214 | 0.129 | 0.182 | 0.278 | 0.525 | >99.9% | 0.0100 µg/L | ▽ |
Uranium | Uranium | µg/L | 357 | * | * | * | < LOD | < LOD | 0.0216 | 0.0805 | 49.6% | 0.0100 µg/L | ▽ |
Uranium | Uranium | µg/g creatinine | 357 | * | * | * | < LOD | < LOD | 0.0316 | 0.112 | 49.6% | 0.0100 µg/L | ▽ |
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
Antimony | Antimony | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.0558 | 20.0% | 0.0300 µg/L | ⌂ |
Arsenic | Arsenic | µg/L | 90 | 6.13 | 4.57 | 8.21 | 2.46 | 4.44 | 18.5 | 40.0 | 100% | 0.100 µg/L | ⌂ |
Cadmium | Cadmium | µg/g creatinine | 90 | 0.240 | 0.201 | 0.287 | 0.123 | 0.231 | 0.403 | 0.714 | 91.1% | 0.0300 µg/L | ⌂ |
Cobalt | Cobalt | µg/L | 90 | 0.171 | 0.133 | 0.220 | 0.0715 | 0.182 | 0.319 | 0.846 | 92.2% | 0.0300 µg/L | ⌂ |
Manganese | Manganese | µg/L | 90 | * | * | * | <LOD | <LOD | <LOD | 0.132 | 18.9% | 0.100 µg/L | ⌂ |
Mercury | Mercury | µg/L | 90 | 0.156 | 0.121 | 0.201 | 0.0667 | 0.156 | 0.369 | 0.643 | 88.9% | 0.0300 µg/L | ⌂ |
Molybdenum | Molybdenum | µg/L | 90 | 24.5 | 19.8 | 30.3 | 12.1 | 26.2 | 58.1 | 85.2 | 100% | 0.300 µg/L | ⌂ |
Thallium | Thallium | µg/L | 90 | 0.108 | 0.0909 | 0.129 | 0.0607 | 0.119 | 0.208 | 0.273 | 98.9% | 0.0100 µg/L | ⌂ |
Uranium | Uranium | µg/L | 90 | * | * | * | <LOD | <LOD | 0.0164 | 0.0326 | 40.0% | 0.0100 µg/L | ⌂ |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
Arsenic | Arsenic | μg/L | 101 | 10.8 | 9.03 | 12.9 | 6.05 | 10.4 | 21.0 | 34.9 | 100% | 0.158 |
Cadmium | Cadmium | μg/g creatinine | 101 | 0.145 | 0.132 | 0.160 | <LOD | 0.138 | 0.190 | 0.277 | 69.7% | 0.105 μg/L |
Manganese | Manganese | μg/L | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 9.1% | 0.184 |
Mercury | Mercury | μg/L | 101 | 0.455 | 0.382 | 0.542 | 0.221 | 0.447 | 0.914 | 1.28 | 100% | 0.0522 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
Arsenic | Arsenic | µg/L | 89 | 7.71 | 6.39 | 9.32 | 4.34 | 8.15 | 11.2 | 34.9 | 0.158 |
Cadmium | Cadmium | μg/g creatinine | 89 | 0.185 | 0.160 | 0.213 | <LOD | 0.178 | 0.257 | 0.364 | 0.105 μg/L |
Mercury | Mercury | μg/L | 89 | 0.212 | 0.164 | 0.274 | 0.0897 | 0.176 | 0.429 | 0.997 | 0.0522 |
Chemical Group: Organochlorine Pesticides
- Measured in: Serum
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 110 | 7.00 | 5.42 | 9.05 | 2.98 | 5.94 | 11.5 | 115 | 89.1% | 0.00800 ng/mL |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 110 | 321 | 266 | 386 | 161 | 318 | 585 | 2180 | 100.0% | 0.0160 ng/mL |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.0% | 0.00800 ng/mL |
DDT (para,para) | para,para-DDT | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 10.6 | 15.5% | 0.00800 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 110 | 11.6 | 10.8 | 12.5 | 9.21 | 11.4 | 14.0 | 20.6 | 100.0% | 0.00800 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 110 | 7.61 | 6.41 | 9.02 | 5.45 | 8.30 | 13.2 | 28.4 | 91.8% | 0.00800 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 110 | 14.3 | 12.0 | 17.0 | 8.31 | 14.5 | 25.1 | 60.8 | 99.1% | 0.00800 ng/mL |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 5.22 | 24.7 | 35.5% | 0.00800 ng/mL | ♦ |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 217 | 217 | 176 | 267 | 110 | 174 | 542 | 1240 | 100% | 0.0160 ng/mL | ♦ |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.00800 ng/mL | ♦ |
DDT (para,para) | para,para-DDT | ng/g lipid | 217 | * | * | * | <LOD | 1.71 | 2.58 | 4.98 | 64.2% | 0.00800 ng/mL | ♦ |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 217 | 8.82 | 8.21 | 9.47 | 7.27 | 8.71 | 11.1 | 16.1 | 100% | 0.0106 ng/mL | ♦ |
Oxychlordane | Chlordane | ng/g lipid | 217 | 3.73 | 3.09 | 4.50 | 2.00 | 3.54 | 7.37 | 15.0 | 83.4% | 0.00800 ng/mL | ♦ |
trans-Nonachlor | Chlordane | ng/g lipid | 217 | 6.92 | 5.68 | 8.44 | 3.69 | 6.43 | 14.9 | 34.4 | 89.9% | 0.00800 ng/mL | ♦ |
Project: California Childhood Leukemia Study (CCLS)
- Study Group: 48 Mothers
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 48 | 5.7 | 3.8 | 8.5 | <LOD | 5.9 | 10 | 29 | 69% | 0.010 ng/mL |
DDE (para,para) | DDT (para,para) and/or DDE (para,para) | ng/g lipid | 48 | 190 | 160 | 230 | 120 | 180 | 290 | 420 | 100% | 0.027 ng/mL |
DDT (ortho,para) | DDT (ortho,para) | ng/g lipid | 48 | 3.7 | 3.0 | 4.6 | <LOD | 5.3 | 7.1 | 8.2 | 69% | 0.012 ng/mL |
DDT (para,para) | DDT (para,para) | ng/g lipid | 48 | 4.3 | 3.5 | 5.2 | 3.3 | 4.1 | 6.3 | 9.0 | 88% | 0.010 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 48 | 7.7 | 7.2 | 8.1 | 6.8 | 7.8 | 8.5 | 10 | 100% | 0.010 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 48 | 4.6 | 4.1 | 5.2 | 3.9 | 5.0 | 5.8 | 7.1 | 98% | 0.010 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 48 | 8.8 | 7.7 | 10 | 6.7 | 8.8 | 11 | 15 | 100% | 0.011 ng/mL |
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 793 | 5.21 | 4.88 | 5.57 | 2.79 | 5.24 | 9.66 | 25.3 | 84.5% | 0.015 ng/mL |
DDE (para,para) | DDT (para,para) and/or DDE (para,para) | ng/g lipid | 793 | 301 | 283 | 320 | 159 | 298 | 540 | 1360 | 100% | 0.015 ng/mL |
DDT (ortho,para) | DDT (ortho,para) | ng/g lipid | 793 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.3% | 0.031 ng/mL |
DDT (para,para) | DDT (para,para) | ng/g lipid | 793 | 1.94 | 1.87 | 2.02 | <LOD | 1.84 | 2.58 | 5.47 | 67.7% | 0.015 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 793 | 12 | 11.7 | 12.2 | 9.75 | 11.9 | 14.3 | 20.8 | 100% | 0.015 ng/mL |
Oxychlordane | Oxychlordane | ng/g lipid | 793 | 8.34 | 7.95 | 8.75 | 5.52 | 8.63 | 13 | 23.6 | 98.1% | 0.015 ng/mL |
trans-Nonachlor | t-Nonachlor | ng/g lipid | 793 | 15.3 | 14.6 | 16 | 10.1 | 14.8 | 23.4 | 49.4 | 99.9% | 0.015 ng/mL |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | beta-HCH | ng/g lipid | 101 | 2.19 | 2.00 | 2.41 | 1.68 | 2.23 | 2.83 | 4.64 | 97.0% | 0.005 ng/mL |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 101 | 177 | 161 | 196 | 125 | 182 | 245 | 394 | 100% | 0.009 ng/mL |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.0% | 0.005 ng/mL |
DDT (para,para) | para,para-DDT | ng/g lipid | 101 | 1.34 | 1.20 | 1.50 | <LOD | 1.43 | 2.07 | 3.08 | 74.3% | 0.005 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 101 | 11.8 | 11.3 | 12.4 | 10.3 | 11.7 | 13.2 | 17.6 | 100% | 0.007 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 101 | 4.08 | 3.64 | 4.56 | 2.73 | 4.31 | 5.80 | 9.63 | 99.0% | 0.005 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 101 | 7.32 | 6.57 | 8.15 | 5.07 | 7.32 | 10.2 | 16.6 | 100% | 0.005 ng/mL |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
beta-Hexachlorocyclohexane (beta-HCH) | beta-HCH | ng/g lipid | 77 | * | * | * | <LOD | 1.59 | 6.00 | 13.2 | 0.005 ng/mL |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 77 | 112 | 85.1 | 149 | 53.0 | 94.0 | 161 | 516 | 0.005 ng/mL |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
DDT (para,para) | para,para-DDT | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 18.2 | 0.005 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 77 | 8.26 | 7.58 | 8.99 | 6.50 | 8.43 | 10.1 | 12.5 | 0.034 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 77 | * | * | * | <LOD | 0.93 | 1.6 | 3.2 | 0.005 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 77 | 1.69 | 1.41 | 2.02 | 1.09 | 1.80 | 2.87 | 4.88 | 0.006 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0107 ng/mL |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 58 | 82.6 | 61.7 | 110 | 38.8 | 72.5 | 155 | 433 | 100% | 0.00837 ng/mL |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0100 ng/mL |
DDT (para,para) | para,para-DDT | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 1.85 | 5.59 | 25.9% | 0.0107 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 58 | 6.41 | 5.85 | 7.03 | 5.24 | 6.14 | 7.43 | 8.93 | 100% | 0.0116 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 1.69 | 20.7% | 0.00618 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0107 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 242 | * | * | * | <LOD | 3.05 | 4.39 | 7.84 | 64.5% | 0.0160 and 0.0180 ng/mL** |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 242 | 47.6 | 42.6 | 53.3 | 29.0 | 41.4 | 65.8 | 221 | 100% | 0.0181 and 0.0359 ng/mL** |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
DDT (para,para) | para,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.98 | 9.1% | 0.0160 and 0.0180 ng/mL** |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 242 | 11.4 | 10.8 | 11.9 | 8.98 | 11.2 | 13.5 | 21.7 | 93.4% | 0.0399 and 0.0875 ng/mL** |
Oxychlordane | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.0160 and 0.0180 ng/mL** |
trans-Nonachlor | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.18 | 24.4% | 0.0160 and 0.0180 ng/mL** |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.12 | 17.6% | 0.0160 ng/mL |
DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 204 | 11.1 | 9.59 | 12.9 | 4.71 | 9.50 | 18.4 | 97.1 | 75.5% | 0.0320 ng/mL |
DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
DDT (para,para) | para,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
Hexachlorobenzene (HCB) | HCB | ng/g lipid | 204 | 10.3 | 10.0 | 10.6 | 8.99 | 10.2 | 11.7 | 14.0 | 100% | 0.0230 ng/mL |
Oxychlordane | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
trans-Nonachlor | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0160 ng/mL |
Chemical Group: Organophosphate Pesticides
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
IMPY | Diazinon | µg/L | 109 | * | * | * | <LOD | <LOD | 0.0944 | 0.708 | 35.8% | 0.0500 µg/L |
TCPy | Chlorpyrifos, Chlorpyrifos-methyl | µg/L | 109 | 1.23 | 1.05 | 1.45 | 0.706 | 1.24 | 2.24 | 4.40 | 80.7% | 0.500 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
IMPY | Diazanon | µg/L | 218 | * | * | * | <LOD | <LOD | 0.199 | 0.849 | 47.5% | 0.0500 µg/L | ● |
IMPY | Diazanon | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.216 | 0.829 | 47.5% | 0.0500 µg/L | ● |
TCPy | Chlorpyrifos (Chlorpyrifos methyl) | µg/L | 218 | 0.912 | 0.792 | 1.05 | <LOD | 0.991 | 1.39 | 2.72 | 74.6% | 0.500 µg/L | ● |
TCPy | Chlorpyrifos (Chlorpyrifos methyl) | µg/g creatinine | 218 | 0.997 | 0.883 | 1.13 | <LOD | 0.953 | 1.40 | 2.61 | 74.6% | 0.500 µg/L | ● |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
IMPY | Diazinon | μg/L | 101 | 0.16 | 0.12 | 0.20 | <LOD | 0.18 | 0.42 | 1.2 | 66.3% | 0.050 |
TCPy | Chlorpyrifos | μg/L | 101 | 1.78 | 1.47 | 2.15 | 0.823 | 1.96 | 3.32 | 10.4 | 89.1% | 0.50 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
DEDTP | Phorate and others | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.10 |
DEP | Chlorpyrifos, diazinon, and others | μg/L | 89 | 1.41 | 1.10 | 1.80 | <LOD | 1.76 | 3.51 | 6.79 | 0.50 |
DMDTP | Dimethoate, malathion, methidathion, phosmet, and others | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0 |
DMTP | Dimethoate, malathion, methidathion, phosmet, and others | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.50 |
TCPy | Chlorpyrifos | μg/L | 89 | 0.52 | 0.41 | 0.65 | <LOD | 0.53 | 1.2 | 2.2 | 0.20 |
Chemical Group: Other Pesticides
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
DEET | DEET | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 0.502 | 12.8% | 0.0500 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
DEET | DEET | µg/L | 218 | * | * | * | <LOD | <LOD | 0.102 | 0.286 | 38.5% | 0.0500 µg/L | ● |
DEET | DEET | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | 0.117 | 0.425 | 38.5% | 0.0500 µg/L | ● |
Chemical Group: Perchlorate
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Perchlorate | µg/L | 102 | 3.77 | 3.23 | 4.39 | 2.26 | 3.76 | 5.95 | 13.9 | 100% | 0.500 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Perchlorate | µg/L | 218 | 2.91 | 2.38 | 3.56 | 2.00 | 2.98 | 4.59 | 18.6 | 100% | 0.0100 µg/L | ● | |
Perchlorate | µg/g creatinine | 218 | 3.19 | 2.68 | 3.79 | 1.79 | 2.87 | 5.47 | 13.9 | 100% | 0.0100 µg/L | ● |
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 1
- Study Group: 100 Chinese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
4:2 FTS | 4:2 FTS | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
5:3 FTCA | 5:3 FTCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
6:2 diPAP | 6:2 diPAP | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 |
6:2 FTCA | 6:2 FTCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
6:2 FTS | 6:2 FTS | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
6:2 FTUCA | 6:2 FTUCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
6:6 PFPiA | 6:6 PFPiA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
6:8 PFPiA | 6:8 PFPiA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
7:3 FTCA | 7:3 FTCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
8:2 diPAP | 8:2 diPAP | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
8:2 FTCA | 8:2 FTCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
8:2 FTS | 8:2 FTS | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
8:2 FTUCA | 8:2 FTUCA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
8:2 PAP | 8:2 PAP | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0500 |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/ml | 96 | 0.0523 | 0.0421 | 0.0650 | 0.0256 | 0.0467 | 0.0959 | 0.228 | 95.8% | 0.0120 |
PFBA | PFBA | ng/ml | 96 | * | * | * | <LOD | 0.0582 | 0.0846 | 0.140 | 62.5% | 0.0500 |
PFBS | PFBS | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0442 |
PFDA | PFDA | ng/ml | 96 | 0.477 | 0.406 | 0.559 | 0.281 | 0.453 | 0.739 | 1.49 | 80.2% | 0.250 |
PFDoA | PFDoA | ng/ml | 96 | * | * | * | <LOD | 0.0540 | 0.0788 | 0.134 | 56.3% | 0.0500 |
PFDS | PFDS | ng/ml | 96 | * | * | * | <LOD | 0.0104 | 0.0204 | 0.048 | 53.1% | 0.00965 |
PFHpA | PFHpA | ng/ml | 96 | * | * | * | <LOD | <LOD | 0.0574 | 0.0868 | 30.2% | 0.0500 |
PFHxA | PFHxA | ng/ml | 96 | 0.176 | 0.162 | 0.191 | 0.151 | 0.180 | 0.214 | 0.276 | 97.9% | 0.0556 |
PFHxPA | PFHxPA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFHxS | PFHxS | ng/ml | 96 | 0.767 | 0.66 | 0.891 | 0.432 | 0.789 | 1.41 | 1.81 | 100% | 0.00945 |
PFNA | PFNA | ng/ml | 96 | 0.987 | 0.870 | 1.12 | 0.65 | 0.948 | 1.33 | 2.24 | 99% | 0.250 |
PFOA | PFOA | ng/ml | 96 | 1.41 | 1.23 | 1.61 | 0.998 | 1.36 | 2.16 | 2.85 | 100% | 0.0500 |
PFOPA | PFOPA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFOS | PFOS | ng/ml | 96 | 6.51 | 5.49 | 7.73 | 3.32 | 6.05 | 11.7 | 19.3 | 100% | 0.0566 |
PFOSA | PFOSA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
PFPeA | PFPeA | ng/ml | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFUnDA | PFUnDA | ng/ml | 96 | 0.398 | 0.348 | 0.455 | 0.301 | 0.427 | 0.600 | 0.824 | 100% | 0.0500 |
Project: Asian/Pacific Islander Community Exposures (ACE) Project - ACE 2
- Study Group: 100 Vietnamese adults living in the San Francisco Bay area
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
4:2 FTS | 4:2 FTS | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
5:3 FTCA | 5:3 FTCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
6:2 diPAP | 6:2 diPAP | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.0500 |
6:2 FTCA | 6:2 FTCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
6:2 FTS | 6:2 FTS | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
6:2 FTUCA | 6:2 FTUCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
6:6 PFPiA | 6:6 PFPiA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0100 |
6:8 PFPiA | 6:8 PFPiA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
7:3 FTCA | 7:3 FTCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.1% | 0.0500 |
8:2 diPAP | 8:2 diPAP | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 |
8:2 FTCA | 8:2 FTCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
8:2 FTS | 8:2 FTS | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
8:2 FTUCA | 8:2 FTUCA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0120 |
8:2 PAP | 8:2 PAP | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.500 |
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0500 |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/ml | 99 | 0.0342 | 0.0291 | 0.0402 | 0.0197 | 0.0282 | 0.0538 | 0.114 | 97% | 0.0120 |
PFBA | PFBA | ng/ml | 99 | 0.0589 | 0.0531 | 0.0655 | <LOD | 0.0580 | 0.0736 | 0.0996 | 67.7% | 0.0500 |
PFBS | PFBS | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0400 |
PFDA | PFDA | ng/ml | 99 | 0.559 | 0.490 | 0.636 | 0.393 | 0.541 | 0.823 | 1.28 | 87.9% | 0.250 |
PFDoA | PFDoA | ng/ml | 99 | * | * | * | <LOD | 0.0135 | 0.0226 | 0.0441 | 52.5% | 0.0500 |
PFDS | PFDS | ng/ml | 99 | * | * | * | <LOD | 0.0505 | 0.0773 | 0.127 | 59.6% | 0.0100 |
PFHpA | PFHpA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | 0.0699 | 20.2% | 0.0500 |
PFHxA | PFHxA | ng/ml | 99 | 0.189 | 0.166 | 0.215 | 0.124 | 0.174 | 0.268 | 0.453 | 98% | 0.0600 |
PFHxPA | PFHxPA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFHxS | PFHxS | ng/ml | 99 | 1.29 | 1.14 | 1.45 | 0.787 | 1.21 | 1.81 | 3.05 | 100% | 0.0100 |
PFNA | PFNA | ng/ml | 99 | 1.10 | 0.988 | 1.22 | 0.84 | 1.08 | 1.49 | 2.21 | 99% | 0.250 |
PFOA | PFOA | ng/ml | 99 | 1.69 | 1.51 | 1.88 | 1.20 | 1.61 | 2.30 | 3.06 | 100% | 0.0600 |
PFOPA | PFOPA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFOS | PFOS | ng/ml | 99 | 7.47 | 6.38 | 8.75 | 4.17 | 7.00 | 11.5 | 22.9 | 100% | 0.191 |
PFOSA | PFOSA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3% | 0.0100 |
PFPeA | PFPeA | ng/ml | 99 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 |
PFUnDA | PFUnDA | ng/ml | 99 | 0.453 | 0.391 | 0.525 | 0.309 | 0.443 | 0.740 | 1.12 | 98% | 0.0500 |
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 110 | * | * | * | <LOD | <LOD | 0.022 | 0.163 | 24.5% | 0.0313 ng/mL |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 110 | 0.174 | 0.142 | 0.213 | 0.0945 | 0.165 | 0.329 | 1.350 | 95.5% | 0.0277 ng/mL |
PFBS | PFBS | ng/mL | 110 | * | * | * | <LOD | <LOD | <LOD | 0.0680 | 11.8% | 0.0411 ng/mL |
PFDA | PFDA | ng/mL | 110 | 0.245 | 0.216 | 0.278 | 0.160 | 0.254 | 0.334 | 0.767 | 100% | 0.0349 ng/mL |
PFDoA | PFDoA | ng/mL | 110 | 0.0191 | 0.0166 | 0.0221 | <LOD | 0.0193 | 0.0303 | 0.0595 | 70.0% | 0.0114 ng/mL |
PFHpA | PFHpA | ng/mL | 110 | 0.0483 | 0.0395 | 0.0591 | 0.0246 | 0.0543 | 0.0901 | 0.269 | 87.3% | 0.010 ng/mL |
PFHxS | PFHxS | ng/mL | 110 | 1.43 | 1.19 | 1.73 | 0.917 | 1.52 | 2.43 | 6.87 | 99.1% | 0.0206 ng/mL |
PFNA | PFNA | ng/mL | 110 | 0.994 | 0.920 | 1.07 | 0.730 | 0.984 | 1.35 | 1.86 | 100% | 0.0154 ng/mL |
PFOA | PFOA | ng/mL | 110 | 1.97 | 1.76 | 2.19 | 1.36 | 1.99 | 2.92 | 4.70 | 100% | 0.0087 ng/mL |
PFOS | PFOS | ng/mL | 110 | 7.00 | 6.12 | 8.00 | 4.66 | 7.10 | 10.4 | 25.8 | 100% | 0.0621 ng/mL |
PFOSA | PFOSA | ng/mL | 110 | * | * | * | <LOD | 0.0254 | 0.0487 | 0.195 | 52.7% | 0.0225 ng/mL |
PFUnDA | PFUnDA | ng/mL | 110 | 0.128 | 0.111 | 0.148 | 0.0737 | 0.123 | 0.195 | 0.533 | 100% | 0.0254 ng/mL |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 337 | * | * | * | <LOD | 0.00732 | 0.0218 | 0.0865 | 51.7% | 0.00682 ng/mL | ○ |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 337 | 0.120 | 0.106 | 0.136 | 0.0686 | 0.124 | 0.202 | 0.514 | 98.4% | 0.0114 ng/mL | ○ |
PFDA | PFDA | ng/mL | 337 | 0.162 | 0.146 | 0.180 | 0.0901 | 0.161 | 0.262 | 0.522 | 79.1% | 0.0877 ng/mL | ○ |
PFDoA | PFDoA | ng/mL | 337 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.148 ng/mL | ○ |
PFHpA | PFHpA | ng/mL | 337 | * | * | * | <LOD | 0.0189 | 0.0480 | 0.135 | 61.4% | 0.0121 ng/mL | ○ |
PFHxS | PFHxS | ng/mL | 337 | 1.09 | 0.952 | 1.26 | 0.606 | 1.13 | 1.85 | 4.59 | 99.5% | 0.0538 ng/mL | ○ |
PFNA | PFNA | ng/mL | 337 | 0.739 | 0.660 | 0.827 | 0.497 | 0.764 | 1.18 | 1.95 | 99.5% | 0.0282 ng/mL | ○ |
PFOA | PFOA | ng/mL | 337 | 1.42 | 1.26 | 1.60 | 1.04 | 1.63 | 2.34 | 4.07 | 99.5% | 0.0426 ng/mL | ○ |
PFOS | PFOS | ng/mL | 337 | 5.07 | 4.53 | 5.68 | 3.41 | 5.05 | 7.82 | 17.6 | 99.7% | 0.0943 ng/mL | ○ |
PFOSA | PFOSA | ng/mL | 337 | * | * | * | <LOD | <LOD | 0.0246 | 0.108 | 29.2% | 0.0212 ng/mL | ○ |
PFUnDA | PFUnDA | ng/mL | 337 | 0.0841 | 0.0743 | 0.0952 | 0.0447 | 0.0820 | 0.138 | 0.363 | 80.3% | 0.0371 ng/mL | ○ |
Project: California Regional Exposure Study, Los Angeles County (CARE-LA)
- Study Group: 430 adults (age 18 and up) living in Los Angeles County
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0147 | 0.0554 | 35.7% | 0.0115 ng/mL | ▶ |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 425 | 0.0678 | 0.0589 | 0.0780 | 0.0396 | 0.0558 | 0.0953 | 0.340 | 100% | 0.0114 ng/mL | ▶ |
PFBS | PFBS | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | 0.0357 | 5.5% | 0.0303 ng/mL | ▶ |
PFDA | PFDA | ng/mL | 425 | * | * | * | <LOD | 0.0795 | 0.164 | 0.321 | 62.3% | 0.0560 ng/mL | ▶ |
PFDoA | PFDoA | ng/mL | 425 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.110 ng/mL | ▶ |
PFHpA | PFHpA | ng/mL | 425 | * | * | * | <LOD | 0.0280 | 0.0447 | 0.0981 | 52.0% | 0.0256 ng/mL | ▶ |
PFHxS | PFHxS | ng/mL | 425 | 0.689 | 0.585 | 0.813 | 0.418 | 0.787 | 1.23 | 2.39 | 98.5% | 0.0177 ng/mL | ▶ |
PFNA | PFNA | ng/mL | 425 | 0.298 | 0.263 | 0.339 | 0.195 | 0.320 | 0.471 | 1.16 | 96.9% | 0.0424 ng/mL | ▶ |
PFOA | PFOA | ng/mL | 425 | 1.04 | 0.920 | 1.17 | 0.732 | 1.17 | 1.52 | 3.06 | 99.8% | 0.0606 ng/mL | ▶ |
PFOS | PFOS | ng/mL | 425 | 2.20 | 1.87 | 2.60 | 1.41 | 2.38 | 3.91 | 8.78 | 98.0% | 0.0615 ng/mL | ▶ |
PFOSA | PFOSA | ng/mL | 425 | * | * | * | <LOD | <LOD | 0.0152 | 0.0611 | 26.7% | 0.0144 ng/mL | ▶ |
PFUnDA | PFUnDA | ng/mL | 425 | 0.0721 | 0.0619 | 0.0840 | 0.0336 | 0.0735 | 0.136 | 0.350 | 77.6% | 0.0285 ng/mL | ▶ |
Project: California Regional Exposure Study, Region 2 (CARE-2)
- Study Group: 359 adults (age 18 and up) living in Riverside, San Bernardino, Imperial, Mono, and Inyo counties
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0312 | 16.4% | 0.0115 ng/mL | ◀ |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 358 | 0.0344 | 0.0298 | 0.0397 | 0.0178 | 0.0355 | 0.0580 | 0.204 | 81.2% | 0.0114 ng/mL | ◀ |
PFBS | PFBS | ng/mL | 357 | * | * | * | <LOD | <LOD | <LOD | 0.0379 | 9.8% | 0.0303 ng/mL | ▽ |
PFDA | PFDA | ng/mL | 358 | * | * | * | <LOD | 0.0768 | 0.144 | 0.252 | 63.3% | 0.0560 ng/mL | ◀ |
PFDoA | PFDoA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.01% | 0.110 ng/mL | ◀ |
PFHpA | PFHpA | ng/mL | 358 | * | * | * | <LOD | <LOD | 0.0536 | 0.101 | 43.6% | 0.0256 ng/mL | ◀ |
PFHxS | PFHxS | ng/mL | 358 | 0.798 | 0.669 | 0.953 | 0.465 | 0.837 | 1.72 | 3.20 | 99.8% | 0.0177 ng/mL | ◀ |
PFNA | PFNA | ng/mL | 358 | 0.211 | 0.181 | 0.246 | 0.132 | 0.256 | 0.374 | 0.775 | 89.5% | 0.0424 ng/mL | ◀ |
PFOA | PFOA | ng/mL | 358 | 0.987 | 0.866 | 1.12 | 0.668 | 1.13 | 1.77 | 2.53 | 98.8% | 0.0606 ng/mL | ◀ |
PFOS | PFOS | ng/mL | 357 | 2.41 | 2.05 | 2.82 | 1.48 | 2.88 | 4.89 | 7.14 | 98.5% | 0.0615 ng/mL | ▽ |
PFOSA | PFOSA | ng/mL | 358 | * | * | * | <LOD | <LOD | <LOD | 0.0329 | 14.9% | 0.0144 ng/mL | ◀ |
PFUnDA | PFUnDA | ng/mL | 358 | * | * | * | <LOD | 0.0416 | 0.0929 | 0.258 | 61.3% | 0.0285 ng/mL | ◀ |
Project: California Regional Exposure Study, Region 3 (CARE-3)
- Study Group: 90 adults (age 18 and up) living in San Diego and Orange counties
- Sample Collection Date:
- Study Group Subset: Adults
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0250 | 16.9% | 0.0115 ng/mL | ⌂ |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 88 | 0.0363 | 0.0266 | 0.0494 | <LOD | 0.0332 | 0.082 | 0.238 | 65.9% | 0.0114 ng/mL | ⌂ |
PFBS | PFBS | ng/mL | 79 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0303 ng/mL | ⌂ |
PFDA | PFDA | ng/mL | 89 | 0.0942 | 0.0802 | 0.111 | <LOD | 0.0926 | 0.174 | 0.234 | 67.4% | 0.0560 ng/mL | ⌂ |
PFDoA | PFDoA | ng/mL | 80 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.110 ng/mL | ⌂ |
PFHpA | PFHpA | ng/mL | 82 | * | * | * | <LOD | <LOD | 0.0377 | 0.0690 | 39.0% | 0.0256 ng/mL | ⌂ |
PFHxS | PFHxS | ng/mL | 89 | 0.670 | 0.517 | 0.868 | 0.393 | 0.796 | 1.33 | 2.69 | 97.8% | 0.0177 ng/mL | ⌂ |
PFNA | PFNA | ng/mL | 89 | 0.295 | 0.245 | 0.356 | 0.216 | 0.335 | 0.524 | 0.762 | 92.1% | 0.0424 ng/mL | ⌂ |
PFOA | PFOA | ng/mL | 89 | 0.901 | 0.733 | 1.11 | 0.702 | 1.03 | 1.48 | 2.21 | 95.5% | 0.0606 ng/mL | ⌂ |
PFOS | PFOS | ng/mL | 89 | 1.75 | 1.34 | 2.28 | 1.01 | 2.30 | 3.92 | 5.22 | 95.5% | 0.0615 ng/mL | ⌂ |
PFOSA | PFOSA | ng/mL | 89 | * | * | * | <LOD | <LOD | <LOD | 0.0328 | 20.2% | 0.0144 ng/mL | ⌂ |
PFUnDA | PFUnDA | ng/mL | 89 | 0.0804 | 0.066 | 0.098 | 0.0372 | 0.0839 | 0.161 | 0.286 | 80.9% | 0.0285 ng/mL | ⌂ |
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Et-PFOSA-AcOH | EtPFOSAAcOH | ng/mL | 1759 | 0.031 | 0.029 | 0.032 | 0.015 | 0.03 | 0.06 | 0.2 | 84.5% | 0.011 |
Me-PFOSA-AcOH | MePFOSAAcOH | ng/mL | 1759 | 0.2 | 0.19 | 0.21 | 0.1 | 0.2 | 0.41 | 1.3 | 98.4% | 0.013 |
PFBS | PFBS | ng/mL | 614 | *,# | * | * | <LOD | <LOD | <LOD | 0.067 | 18.4% | 0.022 |
PFDA | PFDA | ng/mL | 1759 | 0.22 | 0.21 | 0.23 | 0.15 | 0.23 | 0.35 | 0.67 | 94.7% | 0.032 |
PFDoA | PFDoA | ng/mL | 1737 | * | * | * | <LOD | <LOD | <LOD | 0.093 | 10.8% | 0.036 |
PFHpA | PFHpA | ng/mL | 1759 | 0.054 | 0.052 | 0.057 | <LOD | 0.054 | 0.11 | 0.28 | 74% | 0.015 |
PFHxS | PFHxS | ng/mL | 1759 | 1.62 | 1.56 | 1.68 | 1.04 | 1.58 | 2.50 | 6.24 | 99.9% | 0.012 |
PFNA | PFNA | ng/mL | 1719 | 0.92 | 0.89 | 0.95 | 0.67 | 0.95 | 1.3 | 2.3 | 99.7% | 0.014 |
PFOA | PFOA | ng/mL | 1759 | 2.46 | 2.39 | 2.53 | 1.69 | 2.5 | 3.63 | 6.22 | 99.9% | 0.029 |
PFOS | PFOS | ng/mL | 1759 | 6.8 | 6.56 | 7.04 | 4.57 | 7.14 | 10.9 | 19.5 | 99.8% | 0.083 |
PFOSA | PFOSA | ng/mL | 1597 | 0.036 | 0.034 | 0.039 | <LOD | 0.036 | 0.075 | 0.25 | 74.1% | 0.01 |
PFUnDA | PFUnDA | ng/mL | 1759 | 0.13 | 0.12 | 0.13 | 0.081 | 0.14 | 0.23 | 0.42 | 96.8% | 0.01 |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of detection (LOD) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Et-PFOSA-AcOH | EtPFOSAAcOH | ng/mL | 101 | 0.016 | 0.014 | 0.018 | <LOD | 0.016 | 0.023 | 0.060 | 65.3% | 0.011 |
Me-PFOSA-AcOH | MePFOSAAcOH | ng/mL | 101 | 0.16 | 0.13 | 0.18 | 0.086 | 0.14 | 0.24 | 0.61 | 100% | 0.013 |
PFBS | PFBS | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | 0.020 | 6.9% | 0.02 |
PFDA | PFDA | ng/mL | 101 | 0.899 | 0.783 | 1.03 | 0.512 | 0.721 | 1.72 | 2.63 | 100% | 0.032 |
PFDoA | PFDoA | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.040 |
PFHpA | PFHpA | ng/mL | 101 | 0.13 | 0.11 | 0.15 | 0.06 | 0.12 | 0.22 | 0.63 | 75.2% | 0.059 |
PFHxS | PFHxS | ng/mL | 101 | 2.26 | 2 | 2.54 | 1.61 | 2.27 | 3.13 | 4.64 | 100% | 0.012 |
PFNA | PFNA | ng/mL | 101 | 1.15 | 1.06 | 1.25 | 0.888 | 1.13 | 1.49 | 2.21 | 100% | 0.075 |
PFOA | PFOA | ng/mL | 101 | 3.75 | 3.37 | 4.17 | 2.96 | 3.86 | 4.89 | 9.54 | 100% | 0.301 |
PFOS | PFOS | ng/mL | 101 | 12.5 | 11.3 | 13.8 | 10.1 | 12.7 | 16.8 | 24.7 | 100% | 0.083 |
PFOSA | PFOSA | ng/mL | 101 | 0.032 | 0.027 | 0.037 | 0.019 | 0.029 | 0.050 | 0.151 | 95.0% | 0.009 |
PFUnDA | PFUnDA | ng/mL | 101 | 0.24 | 0.21 | 0.27 | 0.17 | 0.26 | 0.37 | 0.53 | 100% | 0.010 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 77 | * | * | * | <LOD | 0.012 | 0.021 | 0.026 | 0.011 |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 77 | 0.067 | 0.055 | 0.082 | 0.037 | 0.064 | 0.10 | 0.20 | 0.013 |
PFBS | PFBS | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.022 |
PFDA | PFDA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.035 | 0.64 | 0.032 |
PFDoA | PFDoA | ng/mL | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.036 |
PFHpA | PFHpA | ng/mL | 77 | * | * | * | <LOD | <LOD | 0.071 | 0.14 | 0.059 |
PFNA | PFNA | ng/mL | 77 | 0.733 | 0.621 | 0.865 | 0.504 | 0.791 | 1.11 | 1.74 | 0.075 |
PFOA | PFOA | ng/mL | 77 | * | * | * | <LOD | 0.474 | 0.811 | 1.25 | 0.30 |
PFOS | PFOS | ng/mL | 77 | 2.55 | 2.20 | 2.95 | 1.78 | 2.43 | 4.11 | 4.90 | 0.083 |
PFOSA | PFOSA | ng/mL | 77 | 0.019 | 0.016 | 0.022 | 0.012 | 0.017 | 0.026 | 0.049 | 0.01 |
PFUnDA | PFUnDA | ng/mL | 77 | 0.131 | 0.101 | 0.170 | 0.0730 | 0.165 | 0.261 | 0.474 | 0.01 |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
- Study Group Subset: Subsample 2
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.0185 | 0.0288 | 29.0% | 0.0164 ng/mL |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 200 | 0.0446 | 0.0379 | 0.0526 | 0.0177 | 0.0373 | 0.091 | 0.361 | 79.5% | 0.0147 ng/mL |
PFDA | PFDA | ng/mL | 200 | 0.198 | 0.174 | 0.226 | 0.0950 | 0.212 | 0.373 | 0.908 | 83.0% | 0.0652 ng/mL |
PFDoA | PFDoA | ng/mL | 200 | * | * | * | <LOD | <LOD | <LOD | 0.317 | 8.0% | 0.174 ng/mL |
PFHpA | PFHpA | ng/mL | 200 | 0.0453 | 0.0397 | 0.0515 | 0.0220 | 0.0484 | 0.0954 | 0.198 | 83.5% | 0.0149 ng/mL |
PFHxS | PFHxS | ng/mL | 200 | 0.904 | 0.818 | 0.998 | 0.558 | 0.861 | 1.43 | 2.83 | 100% | 0.0250 ng/mL |
PFNA | PFNA | ng/mL | 200 | 0.647 | 0.596 | 0.703 | 0.442 | 0.644 | 0.952 | 1.74 | 100% | 0.0302 ng/mL |
PFOA | PFOA | ng/mL | 200 | 1.243 | 1.154 | 1.339 | 0.898 | 1.29 | 1.77 | 2.81 | 100% | 0.0391 ng/mL |
PFOS | PFOS | ng/mL | 200 | 4.20 | 3.82 | 4.62 | 2.62 | 4.47 | 6.75 | 12.3 | 100% | 0.0565 ng/mL |
PFOSA | PFOSA | ng/mL | 200 | * | * | * | <LOD | <LOD | 0.00661 | 0.0266 | 33.5% | 0.00460 ng/mL |
PFUnDA | PFUnDA | ng/mL | 200 | 0.124 | 0.107 | 0.144 | 0.0483 | 0.118 | 0.275 | 0.717 | 78.0% | 0.0430 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 2
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
4:2 FTS | 4:2 FTS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0463 | 6.2% | 0.0372 ng/mL |
5:3 FTCA | 5:3 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0500 ng/mL |
6:2 diPAP | 6:2 diPAP | ng/mL | 277 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0645 ng/mL |
6:2 FTCA | 6:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
6:2 FTS | 6:2 FTS | ng/mL | 240 | * | * | * | <LOD | <LOD | <LOD | 0.781 | 20.8% | 0.188 ng/mL |
6:2 FTUCA | 6:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
6:6 PFPiA | 6:6 PFPiA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
7:3 FTCA | 7:3 FTCA | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.8% | 0.0622 ng/mL |
8:2 diPAP | 8:2 diPAP | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/ml |
8:2 FTCA | 8:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
8:2 FTS | 8:2 FTS | ng/mL | 290 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.0500 ng/mL |
8:2 FTUCA | 8:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0280 ng/mL |
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0179 | 0.0398 | 35.6% | 0.0131 ng/mL |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.107 | 0.287 | 45.5% | 0.0638 ng/mL |
PFBA | PFBA | ng/mL | 292 | 0.0577 | 0.0550 | 0.0606 | <LOD | 0.0594 | 0.0770 | 0.121 | 65.8% | 0.0500 ng/mL |
PFBS | PFBS | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0119 | 0.0283 | 25.0% | 0.0140 ng/mL |
PFDA | PFDA | ng/mL | 292 | 0.213 | 0.196 | 0.231 | 0.135 | 0.189 | 0.320 | 0.752 | 99.0% | 0.0542 ng/mL |
PFDoA | PFDoA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0854 | 16.4% | 0.0500 ng/mL |
PFDS | PFDS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0308 | 5.8% | 0.0274 ng/mL |
PFHpA | PFHpA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.103 | 24.0% | 0.0500 ng/ml |
PFHxA | PFHxA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0925 | 5.5% | 0.0818 ng/mL |
PFHxPA | PFHxPA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
PFHxS | PFHxS | ng/mL | 292 | 0.743 | 0.690 | 0.800 | 0.496 | 0.720 | 1.00 | 2.66 | 100% | 0.0195 ng/ml |
PFNA | PFNA | ng/mL | 292 | 0.542 | 0.509 | 0.578 | 0.372 | 0.527 | 0.774 | 1.39 | 100% | 0.0487 ng/mL |
PFOA | PFOA | ng/mL | 292 | 1.01 | 0.942 | 1.09 | 0.631 | 1.02 | 1.55 | 2.88 | 100% | 0.0539 ng/mL |
PFOS | PFOS | ng/mL | 292 | 3.10 | 2.88 | 3.33 | 2.05 | 3.09 | 4.41 | 9.07 | 100% | 0.316 ng/mL |
PFOSA | PFOSA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.4% | 0.0173 ng/mL |
PFPeA | PFPeA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0255 | 6.5% | 0.0235 ng/mL |
PFUnDA | PFUnDA | ng/mL | 292 | 0.129 | 0.115 | 0.145 | 0.0646 | 0.118 | 0.275 | 0.726 | 81.2% | 0.0481 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 2
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
4:2 FTS | 4:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0372 ng/mL |
5:3 FTCA | 5:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 ng/mL |
6:2 diPAP | 6:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0645 ng/mL |
6:2 FTCA | 6:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.2% | 0.250 ng/mL |
6:2 FTS | 6:2 FTS | ng/mL | 87 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.188 ng/mL |
6:2 FTUCA | 6:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
6:6 PFPiA | 6:6 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
6:8 PFPiA | 6:8 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.198 ng/mL |
7:3 FTCA | 7:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0622 ng/mL |
8:2 diPAP | 8:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
8:2 FTCA | 8:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
8:2 FTS | 8:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0500 ng/mL |
8:2 FTUCA | 8:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0280 ng/mL |
Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0136 | 11.5% | 0.0131 ng/mL |
Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 22.9% | 0.0638 ng/mL |
PFBA | PFBA | ng/mL | 96 | 0.0760 | 0.0697 | 0.0828 | 0.0645 | 0.0845 | 0.0990 | 0.117 | 82.3% | 0.0500 ng/mL |
PFBS | PFBS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0140 ng/mL |
PFDA | PFDA | ng/mL | 96 | 0.187 | 0.160 | 0.220 | 0.109 | 0.169 | 0.285 | 0.613 | 99.0% | 0.0542 ng/mL |
PFDoA | PFDoA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0741 | 17.7% | 0.0500 ng/mL |
PFDS | PFDS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.3% | 0.0274 ng/mL |
PFHpA | PFHpA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0107 ng/mL |
PFHxA | PFHxA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.108 ng/mL |
PFHxPA | PFHxPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
PFHxS | PFHxS | ng/mL | 96 | 0.416 | 0.366 | 0.473 | 0.272 | 0.386 | 0.606 | 0.951 | 100% | 0.0472 ng/mL |
PFNA | PFNA | ng/mL | 96 | 0.406 | 0.360 | 0.457 | 0.263 | 0.426 | 0.564 | 0.830 | 100% | 0.0767 ng/mL |
PFOA | PFOA | ng/mL | 96 | 0.892 | 0.783 | 1.02 | 0.604 | 0.895 | 1.29 | 2.00 | 100% | 0.0539 ng/mL |
PFOPA | PFOPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
PFOS | PFOS | ng/mL | 96 | 2.39 | 2.08 | 2.75 | 1.47 | 2.47 | 3.56 | 5.42 | 100% | 0.316 ng/mL |
PFOSA | PFOSA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0173 ng/mL |
PFPeA | PFPeA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0235 ng/mL |
PFUnDA | PFUnDA | ng/mL | 96 | 0.121 | 0.0990 | 0.147 | 0.0584 | 0.108 | 0.215 | 0.532 | 79.2% | 0.0481 ng/mL |
Chemical Group: Phthalates
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
MBzP | Benzylbutyl phthalate (BzBP) | µg/L | 109 | 7.49 | 5.99 | 9.36 | 3.65 | 7.27 | 18.6 | 41.9 | 100% | 0.250 µg/L |
MCHP | Dicyclohexyl phthalate (DCHP) | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.83% | 0.500 µg/L |
MCPP | Di-n-octyl phthalate (DnOP) | µg/L | 109 | 1.88 | 1.52 | 2.32 | 1.03 | 1.64 | 3.41 | 14.6 | 100% | 0.125 µg/L |
MECPP | Di-2-ethylhexyl phthalate (DEHP) | µg/L | 109 | 12.1 | 10.0 | 14.7 | 7.10 | 11.7 | 20.0 | 51.7 | 100% | 0.500 µg/L |
MEP | Diethyl phthalate (DEP) | µg/L | 109 | 57.1 | 45.2 | 72.1 | 25.5 | 52.1 | 103 | 584 | 97.2% | 8.00 µg/L |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | µg/L | 109 | 19.0 | 16.1 | 22.4 | 11.7 | 18.5 | 31.6 | 73.5 | 98.2% | 2.00 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
MBzP | Benzylbutyl phthalate (BzBP) | µg/L | 218 | 5.20 | 4.09 | 6.61 | 2.82 | 5.57 | 9.44 | 25.6 | 100% | 0.200 µg/L | ● |
MBzP | Benzylbutyl phthalate (BzBP) | µg/g creatinine | 218 | 5.69 | 4.81 | 6.72 | 3.36 | 5.86 | 9.05 | 22.3 | 100% | 0.200 µg/L | ● |
MCHP | Dicyclohexyl phthalate (DCHP) | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
MCHP | Dicyclohexyl phthalate (DCHP) | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | <LOD | <0.1% | 0.100 µg/L | ● |
MCPP | Di-n-octyl phthalate (DnOP) | µg/L | 218 | 2.01 | 1.57 | 2.58 | 0.943 | 2.30 | 4.40 | 16.0 | >99.9% | 0.100 µg/L | ● |
MCPP | Di-n-octyl phthalate (DnOP) | µg/g creatinine | 218 | 2.20 | 1.79 | 2.71 | 1.17 | 1.87 | 3.54 | 15.2 | >99.9% | 0.100 µg/L | ● |
MECPP | Di-2-ethylhexyl phthalate (DEHP) | µg/L | 218 | 9.62 | 7.62 | 12.1 | 5.35 | 11.0 | 20.5 | 47.9 | 100% | 0.190 µg/L | ● |
MECPP | Di-2-ethylhexyl phthalate (DEHP) | µg/g creatinine | 218 | 10.52 | 9.01 | 12.3 | 6.81 | 10.5 | 16.9 | 36.1 | 100% | 0.190 µg/L | ● |
MEHHP | Di-2-ethylhexyl phthalate (DEHP) | µg/L | 218 | 6.05 | 4.67 | 7.83 | 2.70 | 7.17 | 12.7 | 31.9 | >99.9% | 0.190 µg/L | ● |
MEHHP | Di-2-ethylhexyl phthalate (DEHP) | µg/g creatinine | 218 | 6.61 | 5.50 | 7.94 | 4.33 | 6.75 | 10.4 | 19.6 | >99.9% | 0.190 µg/L | ● |
MEHP | Di-2-ethylhexyl phthalate (DEHP) | µg/L | 218 | 1.89 | 1.38 | 2.59 | 0.857 | 2.28 | 5.21 | 13.3 | 89.9% | 0.190 µg/L | ● |
MEHP | Di-2-ethylhexyl phthalate (DEHP) | µg/g creatinine | 218 | 2.07 | 1.63 | 2.62 | 0.936 | 2.16 | 4.24 | 12.9 | 89.9% | 0.190 µg/L | ● |
MEOHP | Di-2-ethylhexyl phthalate (DEHP) | µg/L | 218 | 4.49 | 3.43 | 5.87 | 2.37 | 4.87 | 8.27 | 35.0 | >99.9% | 0.100 µg/L | ● |
MEOHP | Di-2-ethylhexyl phthalate (DEHP) | µg/g creatinine | 218 | 4.91 | 4.02 | 6.00 | 3.00 | 4.96 | 7.06 | 21.5 | >99.9% | 0.100 µg/L | ● |
MEP | Diethyl phthalate (DEP) | µg/L | 218 | 52.6 | 38.5 | 72.0 | 20.7 | 43.0 | 118 | 930 | 100% | 0.460 µg/L | ● |
MEP | Diethyl phthalate (DEP) | µg/g creatinine | 218 | 57.5 | 44.3 | 74.6 | 23.9 | 46.2 | 120 | 534 | 100% | 0.460 µg/L | ● |
MIBP | Di-isobutyl phthalate (DIBP) | µg/L | 218 | 6.88 | 5.70 | 8.32 | 3.84 | 6.35 | 12.2 | 25.4 | 93.3% | 1.60 µg/L | ● |
MIBP | Di-isobutyl phthalate (DIBP) | µg/g creatinine | 218 | 7.52 | 6.50 | 8.72 | 4.91 | 7.22 | 11.5 | 27.5 | 93.3% | 1.60 µg/L | ● |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | µg/L | 218 | 13.8 | 11.0 | 17.4 | 7.75 | 15.7 | 25.4 | 69.9 | 96.8% | 0.910 µg/L | ● |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | µg/g creatinine | 218 | 15.1 | 12.9 | 17.7 | 8.67 | 15.4 | 22.5 | 51.8 | 96.8% | 0.910 µg/L | ● |
Project: Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS)
- Study Group: 49 Children aged 5 years old
- Sample Collection Date: -
- Study Group Subset: Children
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
MEP | Diethyl phthalate (DEP) | μg/L | 49 | 85 | 63.1 | 115 | 41.3 | 70.0 | 211 | 403 | 100% | 8.0 |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | μg/L | 49 | 46.9 | 37.0 | 59.4 | 26.8 | 49.0 | 75.2 | 115 | 100% | 2.0 |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
MBzP | Benzylbutyl phthalate (BzBP) | μg/L | 101 | 8.18 | 6.56 | 10.2 | 3.93 | 7.76 | 14.9 | 41.3 | 100% | 0.25 |
MCHP | Dicyclohexyl phthalate (DCHP) | μg/L | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.0% | 0.50 |
MCPP | Di-n-octyl phthalate (DnOP) | μg/L | 101 | 1.88 | 1.46 | 2.42 | 0.819 | 1.69 | 4.07 | 21.1 | 98.0% | 0.125 |
MECPP | Di-2-ethylhexyl phthalate (DEHP) | μg/L | 101 | 12.3 | 10.1 | 14.9 | 5.89 | 12.4 | 23.2 | 58.3 | 100% | 0.50 |
MEP | Diethyl phthalate (DEP) | μg/L | 101 | 52.9 | 38.1 | 73.4 | 20.6 | 46.6 | 168 | 740 | 79.2% | 8.0 |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | μg/L | 101 | 10.6 | 8.83 | 12.8 | 5.69 | 10.6 | 20.2 | 40.6 | 97.0% | 2.0 |
Project: Markers of Autism Risk in Babies–Learning Early Signs (MARBLES)
- Study Group: 15 Pregnant women who have a biological child with autism spectrum disorder
- Sample Collection Date: -
- Study Group Subset: Pregnant women_measurement 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
MEP | Diethyl phthalate (DEP) | μg/L | 15 | 62.4 | 32.2 | 121 | -- | 52.6 | -- | -- | 100% | 8.0 |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | μg/L | 15 | 21.9 | 14.4 | 33.5 | -- | 21.3 | -- | -- | 100% | 2.0 |
- Study Group Subset: Pregnant women_measurement 2
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
MEP | Diethyl phthalate (DEP) | μg/L | 13 | 65.1 | 26.0 | 163 | -- | 31.5 | -- | -- | 100% | 8.0 |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | μg/L | 13 | 21.1 | 10.8 | 41.2 | -- | 23.2 | -- | -- | 100% | 2.0 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
MBzP | Benzylbutyl phthalate (BzBP) | μg/L | 89 | 7.73 | 5.84 | 10.2 | 2.72 | 6.54 | 18.4 | 53.4 | 0.25 |
MCHP | Dicyclohexyl phthalate (DCHP) | μg/L | 89 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.50 |
MCPP | Di-n-octyl phthalate (DnOP) | μg/L | 89 | 0.87 | 0.72 | 1.05 | 0.48 | 0.75 | 1.2 | 2.8 | 0.125 |
MECPP | Di-2-ethylhexyl phthalate (DEHP) | μg/L | 89 | 17.1 | 13.5 | 21.7 | 8.09 | 14.6 | 29.4 | 68.8 | 0.50 |
MEP | Diethyl phthalate (DEP) | μg/L | 89 | 95.5 | 69.3 | 132 | 34.7 | 103 | 254 | 679 | 8.0 |
MnBP | Dibutyl phthalate (DBP), Benzylbutyl phthalate (BzBP) | μg/L | 89 | 16.3 | 13.0 | 20.5 | 6.59 | 16.2 | 34.2 | 60.8 | 2.0 |
Chemical Group: Polybrominated Diphenyl Ethers (PBDEs)
- Measured in: Serum
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.8% | 0.003 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 110 | 1.81 | 1.52 | 2.16 | 1.02 | 1.64 | 2.63 | 10.2 | 91.8% | 0.003 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 110 | 25.8 | 21.0 | 31.6 | 12.3 | 26.9 | 43.2 | 134 | 99.1% | 0.023 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 1.02 | 9.1% | 0.004 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 3.49 | 20.0% | 0.004 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 110 | 4.75 | 3.85 | 5.85 | 2.08 | 4.30 | 8.36 | 54.7 | 80.9% | 0.012 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 110 | 4.02 | 3.24 | 4.98 | 2.07 | 3.72 | 6.75 | 39.1 | 89.1% | 0.006 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 110 | 13.9 | 11.6 | 16.8 | 7.08 | 12.5 | 24.6 | 98.4 | 99.1% | 0.008 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 5.12 | 17.3% | 0.007 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.6% | 0.007 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.7% | 0.010 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.76 | 4.38 | 42.7% | 0.007 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.006 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.007 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.007 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.009 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | 2.57 | 18.2% | 0.011 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.7% | 0.010 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 5.65 | 15.5 | 38.2% | 0.030 ng/mL |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
BDE 017 | BDE 17 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.00770 ng/mL | ♦ * |
BDE 028 | BDE 28 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.61 | 5.04 | 47.4% | 0.00800 ng/mL | ♦ |
BDE 047 | BDE 47 | ng/g lipid | 217 | 20.8 | 17.2 | 25.2 | 9.64 | 22.0 | 42.8 | 108 | 99.2% | 0.0165 ng/mL | ♦ |
BDE 066 | BDE 66 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.6% | 0.00800 ng/mL | ♦ |
BDE 085 | BDE 85 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
BDE 099 | BDE 99 | ng/g lipid | 217 | 4.35 | 3.57 | 5.3 | 2.06 | 3.97 | 9.65 | 22.6 | 88.1% | 0.00898 ng/mL | ♦ |
BDE 100 | BDE 100 | ng/g lipid | 217 | 4.21 | 3.44 | 5.14 | 1.67 | 4.18 | 9.14 | 23.6 | 84.9% | 0.00800 ng/mL | ♦ |
BDE 153 | BDE 153 | ng/g lipid | 217 | 11.3 | 9.29 | 13.7 | 6.43 | 10.0 | 16.8 | 83.0 | 94.6% | 0.0160 ng/mL | ♦ |
BDE 154 | BDE 154 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.3% | 0.0160 ng/mL | ♦ |
BDE 183 | BDE 183 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.9% | 0.0160 ng/mL | ♦ |
BDE 196 | BDE 196 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
BDE 197 | BDE 197 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.53 | 7.4% | 0.0160 ng/mL | ♦ |
BDE 201 | BDE 201 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
BDE 202 | BDE 202 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
BDE 203 | BDE 203 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0160 ng/mL | ♦ |
BDE 206 | BDE 206 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
BDE 207 | BDE 207 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.9% | 0.0200 ng/mL | ♦ |
BDE 208 | BDE 208 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.0200 ng/mL | ♦ |
BDE 209 | BDE 209 | ng/g lipid | 190 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.4% | 0.257 ng/mL | ♦ |
Project: California Childhood Leukemia Study (CCLS)
- Study Group: 48 Mothers
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
BDE 047 | BDE 47 | ng/g lipid | 48 | 43 | 33 | 56 | 23 | 35 | 68 | 110 | 98% | 0.074 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 48 | 11 | 8.5 | 14 | 6.5 | 10.1 | 12.7 | 25 | 100% | 0.018 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 48 | 12 | 10 | 15 | 8.0 | 10 | 15 | 22 | 100% | 0.015 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 48 | 10 | 7.6 | 14 | 5.0 | 8.9 | 16 | 46 | 96% | 0.015 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 48 | * | * | * | <LOD | <LOD | 3.6 | 5.7 | 48% | 0.015 ng/mL |
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.2% | 0.006 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | 1.96 | 4.73 | 42.9% | 0.008 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 1980 | 14.1 | 13.6 | 14.7 | 7.22 | 13.1 | 25.3 | 73.5 | 86.4% | 0.024 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.05% | 0.007 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | 1.87 | 7.8% | 0.002 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | 5 | 16 | 44.3% | 0.018 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 1980 | 2.62 | 2.5 | 2.73 | 1.19 | 2.31 | 4.71 | 15.7 | 75.9% | 0.004 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 1980 | 5.6 | 5.34 | 5.85 | 2.66 | 4.75 | 9.48 | 43.1 | 77% | 0.009 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.9% | 0.007 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.007 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2% | 0.003 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | 3.58 | 8.4% | 0.005 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.005 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.005 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 1980 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.005 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 1862 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.004 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 1857 | * | * | * | <LOD | <LOD | <LOD | 4.56 | 9.3% | 0.006 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 1814 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.7% | 0.003 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 1797 | * | * | * | <LOD | <LOD | <LOD | 33.3 | 8.7% | 0.053 ng/mL |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.003 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 101 | 1.70 | 1.50 | 1.93 | 1.17 | 1.63 | 2.38 | 5.09 | 97.0% | 0.003 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 101 | 32.2 | 27.8 | 37.5 | 19.3 | 29.9 | 47.9 | 150 | 99.0% | 0.038 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 0.635 | 5.9% | 0.003 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 0.655 | 1.82 | 34.7% | 0.003 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 101 | 6.19 | 5.35 | 7.17 | 3.54 | 5.79 | 9.12 | 22.6 | 90.1% | 0.017 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 101 | 5.68 | 4.77 | 6.75 | 3.31 | 5.14 | 8.14 | 32.7 | 98.0% | 0.005 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 101 | 15.4 | 12.9 | 18.2 | 9.01 | 12.9 | 21.1 | 63.1 | 100% | 0.005 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 2.71 | 19.8% | 0.007 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.007 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.007 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 101 | * | * | * | <LOD | 1.25 | 1.93 | 3.84 | 62.4% | 0.007 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.007 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.007 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.007 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 1.99 | 11.9% | 0.009 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 101 | * | * | * | <LOD | 1.31 | 1.72 | 4.53 | 50.5% | 0.009 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | <LOD | 1.59 | 7.9% | 0.009 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 28.3 | 93.7 | 28.7% | 0.150 ng/mL |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
BDE 017 | BDE 17 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.75 | 1.6 | 0.005 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 77 | 9.56 | 7.54 | 12.1 | 4.67 | 8.34 | 16.0 | 33.0 | 0.023 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.005 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 77 | * | * | * | <LOD | 2.74 | 5.02 | 9.92 | 0.019 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 77 | 2.17 | 1.70 | 2.77 | 0.960 | 1.96 | 3.95 | 8.11 | 0.005 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 77 | 2.64 | 2.01 | 3.47 | 0.980 | 1.94 | 7.66 | 14.9 | 0.005 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.93 | 1.5 | 0.007 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.007 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.07 | 0.009 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 77 | * | * | * | <LOD | 5.41 | 9.31 | 13.5 | 0.045 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0107 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 58 | 13.7 | 11.1 | 16.8 | 6.57 | 13.9 | 22.8 | 38.7 | 75.9% | 0.0427 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 6.86 | 17.7 | 43.1% | 0.0233 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 58 | * | * | * | <LOD | 2.57 | 5.04 | 12.4 | 62.1% | 0.0107 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 58 | * | * | * | <LOD | 6.05 | 10.9 | 22.2 | 63.8% | 0.0233 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0233 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0160 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 13.6 | 33.4 | 46.5% | 0.0640 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0160 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 4.97 | 11.5 | 26.9% | 0.0350 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 3.59 | 8.99 | 46.5% | 0.0160 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 245 | * | * | * | <LOD | 6.68 | 11.3 | 25.2 | 58.4% | 0.0320 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0320 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0320 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0400 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0400 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0400 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.300 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
BDE 017 | BDE 17 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
BDE 028 | BDE 28 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
BDE 047 | BDE 47 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 4.05 | 8.30 | 34.8% | 0.0240 ng/mL |
BDE 066 | BDE 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
BDE 085 | BDE 85 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
BDE 099 | BDE 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.80 | 11.7% | 0.0220 ng/mL |
BDE 100 | BDE 100 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
BDE 153 | BDE 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 13.8 | 24.5% | 0.0320 ng/mL |
BDE 154 | BDE 154 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 183 | BDE 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 196 | BDE 196 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 197 | BDE 197 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0320 ng/mL |
BDE 201 | BDE 201 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 202 | BDE 202 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 203 | BDE 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
BDE 206 | BDE 206 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
BDE 207 | BDE 207 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0400 ng/mL |
BDE 208 | BDE 208 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
BDE 209 | BDE 209 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.5% | 0.300 ng/mL |
Chemical Group: Polychlorinated Biphenyls (PCBs)
- Measured in: Serum
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
PCB 066 | PCB 066 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.45 | 2.84 | 38.2% | 0.00800 ng/mL |
PCB 074 | PCB 074 | ng/g lipid | 110 | 3.63 | 3.12 | 4.23 | 1.91 | 3.27 | 7.18 | 13.1 | 92.7% | 0.00800 ng/mL |
PCB 099 | PCB 099 | ng/g lipid | 110 | 2.89 | 2.49 | 3.36 | 1.61 | 2.81 | 4.31 | 11.9 | 85.5% | 0.00800 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.36 | 2.34 | 28.2% | 0.00800 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 110 | * | * | * | <LOD | <LOD | 1.73 | 4.54 | 41.8% | 0.00800 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 110 | 4.84 | 4.10 | 5.71 | 2.43 | 4.14 | 8.48 | 19.8 | 96.4% | 0.00800 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 110 | 9.60 | 8.11 | 11.4 | 5.18 | 9.81 | 16.7 | 43.4 | 98.2% | 0.00800 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 110 | 22.0 | 18.5 | 26.1 | 12.8 | 24.7 | 40.5 | 99.0 | 99.1% | 0.00800 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 110 | 3.48 | 2.99 | 4.06 | 1.85 | 3.66 | 5.69 | 13.7 | 85.5% | 0.00800 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 110 | 6.30 | 5.36 | 7.40 | 3.99 | 6.85 | 11.9 | 23.2 | 92.7% | 0.00800 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 110 | 21.8 | 18.2 | 26.2 | 13.8 | 25.7 | 41.9 | 79.6 | 99.1% | 0.00800 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 110 | 2.00 | 1.75 | 2.29 | <LOD | 1.90 | 3.26 | 8.51 | 66.4% | 0.00800 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 110 | 6.38 | 5.37 | 7.58 | 3.60 | 6.90 | 11.7 | 25.0 | 91.8% | 0.00800 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 110 | 5.24 | 4.45 | 6.17 | 2.96 | 5.50 | 9.87 | 19.2 | 89.1% | 0.00800 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 110 | 3.15 | 2.71 | 3.66 | 1.55 | 3.41 | 5.35 | 10.8 | 81.8% | 0.00800 ng/mL |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
PCB 066 | PCB 066 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 1.94 | 9.7% | 0.00800 ng/mL | ♦ |
PCB 074 | PCB 074 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 4.27 | 11.6 | 47.1% | 0.00800 ng/mL | ♦ |
PCB 099 | PCB 099 | ng/g lipid | 217 | * | * | * | <LOD | 1.61 | 3.10 | 8.05 | 58.0% | 0.00800 ng/mL | ♦ |
PCB 101 | PCB 101 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.5% | 0.00800 ng/mL | ♦ |
PCB 105 | PCB 105 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | <LOD | 3.47 | 18.9% | 0.00800 ng/mL | ♦ |
PCB 118 | PCB 118 | ng/g lipid | 217 | 2.85 | 2.34 | 3.46 | 1.29 | 2.52 | 4.78 | 13.4 | 77.5% | 0.00800 ng/mL | ♦ |
PCB 138 | PCB 138 | ng/g lipid | 217 | 5.11 | 4.08 | 6.39 | 2.32 | 4.32 | 10.6 | 25.6 | 93.1% | 0.00800 ng/mL | ♦ |
PCB 153 | PCB 153 | ng/g lipid | 217 | 10.1 | 7.88 | 12.8 | 4.00 | 9.18 | 26.2 | 56.5 | 99.7% | 0.00800 ng/mL | ♦ |
PCB 156 | PCB 156 | ng/g lipid | 217 | * | * | * | <LOD | 1.53 | 3.45 | 7.94 | 52.6% | 0.00800 ng/mL | ♦ |
PCB 170 | PCB 170 | ng/g lipid | 217 | 3.49 | 2.82 | 4.32 | <LOD | 3.50 | 8.88 | 16.1 | 71.7% | 0.00800 ng/mL | ♦ |
PCB 180 | PCB 180 | ng/g lipid | 217 | 9.42 | 7.26 | 12.2 | 3.07 | 9.40 | 29.3 | 54.0 | 97.7% | 0.00800 ng/mL | ♦ |
PCB 183 | PCB 183 | ng/g lipid | 217 | * | * | * | <LOD | <LOD | 2.67 | 5.13 | 43.7% | 0.00800 ng/mL | ♦ |
PCB 187 | PCB 187 | ng/g lipid | 217 | 3.14 | 2.55 | 3.88 | <LOD | 2.96 | 8.63 | 16.3 | 69.4% | 0.00800 ng/mL | ♦ |
PCB 194 | PCB 194 | ng/g lipid | 217 | * | * | * | <LOD | 2.08 | 5.33 | 11.9 | 58.8% | 0.00800 ng/mL | ♦ |
PCB 203 | PCB 203 | ng/g lipid | 217 | * | * | * | <LOD | 2.33 | 5.57 | 11.5 | 61.5% | 0.00800 ng/mL | ♦ |
Project: California Childhood Leukemia Study (CCLS)
- Study Group: 48 Mothers
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
PCB 028 | PCB 28 | ng/g lipid | 48 | 4.1 | 3.6 | 4.7 | <LOD | 3.6 | 4.3 | 6.8 | 100% | 0.010 ng/mL |
PCB 066 | PCB 66 | ng/g lipid | 48 | 2.2 | 1.9 | 2.4 | 1.7 | 2.3 | 2.9 | 3.4 | 85% | 0.010 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 48 | 3.0 | 2.7 | 3.3 | 2.4 | 3.2 | 3.8 | 4.2 | 98% | 0.010 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 48 | 2.7 | 2.5 | 3.1 | 2.2 | 3.0 | 3.5 | 4.3 | 90% | 0.010 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 48 | 1.7 | 1.5 | 1.9 | <LOD | 1.8 | 2.3 | 2.9 | 65% | 0.010 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 48 | 1.9 | 1.7 | 2.1 | <LOD | 2.0 | 2.5 | 2.7 | 73% | 0.010 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 48 | 4.0 | 3.7 | 4.5 | 3.2 | 4.0 | 5.4 | 6.7 | 100% | 0.010 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 48 | 6.8 | 5.9 | 7.9 | 4.8 | 6.4 | 9.4 | 14 | 100% | 0.010 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 48 | 11 | 8.9 | 13 | 6.5 | 9.7 | 17 | 28 | 100% | 0.010 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 48 | 2.6 | 2.3 | 2.9 | 1.9 | 2.5 | 3.4 | 4.1 | 94% | 0.010 ng/mL |
PCB 167 | PCB 167 | ng/g lipid | 48 | * | * | * | <LOD | 1.6 | 2.1 | 2.3 | 60% | 0.010 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 48 | 4.6 | 4.0 | 5.3 | 3.2 | 4.4 | 6.6 | 9.9 | 100% | 0.010 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 48 | 10 | 8.4 | 12 | 6.1 | 9.3 | 15 | 25 | 100% | 0.010 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 48 | 2.2 | 2.0 | 2.5 | 1.6 | 2.4 | 2.8 | 3.3 | 81% | 0.011 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 48 | 3.5 | 3.1 | 4.1 | 2.5 | 3.4 | 4.6 | 7.2 | 100% | 0.010 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 48 | 3.1 | 2.8 | 3.5 | 2.3 | 3.2 | 4.2 | 5.4 | 100% | 0.010 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 48 | 3.0 | 2.7 | 3.3 | 2.2 | 3.1 | 4.0 | 5.3 | 100% | 0.010 ng/mL |
Project: California Teachers Study (CTS)
- Study Group: 2,869 female professional school employees
- Sample Collection Date:
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
PCB 066 | PCB 66 | ng/g lipid | 793 | * | * | * | <LOD | <LOD | 1.68 | 3.07 | 39.8% | 0.015 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 793 | 5.96 | 5.67 | 6.26 | 3.84 | 6.43 | 9.53 | 17.7 | 96.5% | 0.015 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 793 | 3.11 | 2.97 | 3.27 | 2.01 | 3.07 | 4.82 | 9.73 | 90.4% | 0.015 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 793 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.015 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 793 | * | * | * | <LOD | 1.46 | 2.02 | 4.39 | 53% | 0.015 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 793 | 6.5 | 6.18 | 6.83 | 4.09 | 6.41 | 10.4 | 22 | 99% | 0.015 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 793 | 12.9 | 12.3 | 13.5 | 8.39 | 13.5 | 20.5 | 37.1 | 99.5% | 0.015 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 793 | 28.7 | 27.5 | 30 | 19.5 | 30.1 | 43.6 | 72.9 | 100% | 0.015 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 793 | 4.92 | 4.72 | 5.12 | 3.55 | 5.22 | 7.23 | 11.8 | 96.7% | 0.015 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 793 | 9.18 | 8.82 | 9.55 | 6.68 | 9.68 | 13.5 | 20.7 | 99.4% | 0.015 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 793 | 31.5 | 30.3 | 32.9 | 22.4 | 33.3 | 48.4 | 76.8 | 100% | 0.015 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 793 | 2.37 | 2.27 | 2.47 | 1.65 | 2.4 | 3.5 | 5.98 | 82% | 0.015 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 793 | 7.25 | 6.92 | 7.59 | 4.83 | 7.65 | 11.04 | 20.2 | 98.4% | 0.015 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 793 | 7.52 | 7.23 | 7.83 | 5.37 | 7.83 | 11.09 | 17.88 | 99.6% | 0.015 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 793 | 6.47 | 6.17 | 6.78 | 4.36 | 6.75 | 10.14 | 16.71 | 97.2% | 0.015 ng/mL |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
PCB 066 | PCB 66 | ng/g lipid | 101 | 1.17 | 1.09 | 1.25 | <LOD | 1.19 | 1.41 | 1.88 | 74.3% | 0.007 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 101 | 1.77 | 1.61 | 1.95 | 1.33 | 1.73 | 2.33 | 4.02 | 96.0% | 0.005 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 101 | 1.76 | 1.61 | 1.93 | 1.34 | 1.74 | 2.32 | 3.65 | 98.0% | 0.005 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 101 | * | * | * | <LOD | 1.09 | 1.43 | 1.89 | 50.5% | 0.008 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 101 | * | * | * | <LOD | <LOD | 0.848 | 1.25 | 45.5% | 0.005 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 101 | 2.66 | 2.46 | 2.87 | 2.15 | 2.75 | 3.25 | 5.11 | 99.0% | 0.006 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 101 | 5.53 | 4.98 | 6.15 | 3.55 | 5.54 | 8.04 | 11.9 | 100% | 0.005 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 101 | 12.2 | 10.8 | 13.7 | 8.18 | 12.9 | 18.9 | 29.8 | 100% | 0.005 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 101 | 1.84 | 1.61 | 2.09 | 1.21 | 1.88 | 3.09 | 5.23 | 88.1% | 0.005 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 101 | 3.64 | 3.16 | 4.19 | 2.21 | 3.85 | 5.95 | 10.3 | 97.0% | 0.005 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 101 | 13.4 | 11.7 | 15.4 | 8.44 | 14.7 | 22.4 | 37.7 | 100% | 0.006 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 101 | 1.03 | 0.930 | 1.15 | <LOD | 1.04 | 1.51 | 2.33 | 67.3% | 0.005 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 101 | 2.99 | 2.61 | 3.42 | 1.87 | 2.94 | 5.32 | 7.84 | 97.0% | 0.005 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 101 | 3.37 | 2.89 | 3.93 | 1.91 | 3.38 | 6.04 | 11.4 | 98.0% | 0.005 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 101 | 3.37 | 2.92 | 3.89 | 1.91 | 3.83 | 6.30 | 9.37 | 98.0% | 0.005 ng/mL |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
PCB 066 | PCB 66 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.009 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 1.1 | 0.008 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.23 | 0.014 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 2.63 | 0.016 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.010 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 2.02 | 2.97 | 0.014 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 77 | 1.94 | 1.69 | 2.22 | 1.29 | 1.90 | 2.63 | 4.15 | 0.006 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 77 | 2.98 | 2.57 | 3.46 | 1.95 | 3.02 | 4.29 | 6.59 | 0.011 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 0.89 | 0.005 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 77 | * | * | * | <LOD | 0.65 | 0.92 | 1.7 | 0.005 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 77 | 1.97 | 1.67 | 2.31 | 1.27 | 1.79 | 2.90 | 4.91 | 0.007 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.012 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 1.2 | 1.7 | 0.009 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | <LOD | 1.0 | 0.007 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 77 | * | * | * | <LOD | <LOD | 0.88 | 1.4 | 0.007 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 1
- Study Group: 460 pregnant individuals
- Sample Collection Date:
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | |||||||
PCB 066 | PCB 66 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.00850 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 0.992 | 15.5% | 0.00417 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | 1.14 | 1.69 | 27.6% | 0.00733 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0106 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0107 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 58 | 1.42 | 1.25 | 1.62 | <LOD | 1.54 | 2.08 | 2.59 | 69.0% | 0.00705 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 58 | 2.34 | 1.99 | 2.74 | <LOD | 2.37 | 3.43 | 5.47 | 67.2% | 0.0107 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 58 | 3.16 | 2.59 | 3.85 | 2.05 | 3.01 | 5.20 | 8.05 | 91.4% | 0.00679 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0107 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 58 | * | * | * | <LOD | 1.64 | 2.50 | 2.96 | 63.8% | 0.00696 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 58 | 2.94 | 2.44 | 3.54 | 2.00 | 2.98 | 4.93 | 7.09 | 82.8% | 0.00878 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.9% | 0.0107 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 2.27 | 13.8% | 0.0107 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | <LOD | 8.6% | 0.0107 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 58 | * | * | * | <LOD | <LOD | <LOD | 1.55 | 10.3% | 0.0100 ng/mL |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
PCB 066 | PCB 66 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
PCB 074 | PCB 74 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0160 and 0.0180 ng/mL** |
PCB 099 | PCB 99 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0160 and 0.0180 ng/mL** |
PCB 101 | PCB 101 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
PCB 105 | PCB 105 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
PCB 118 | PCB 118 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.03 | 16.9% | 0.0160 and 0.0180 ng/mL** |
PCB 138 | PCB 138 | ng/g lipid | 242 | * | * | * | <LOD | 2.50 | 3.45 | 5.80 | 56.2% | 0.0160 and 0.0180 ng/mL** |
PCB 153 | PCB 153 | ng/g lipid | 242 | 3.16 | 2.93 | 3.41 | <LOD | 2.89 | 4.41 | 8.25 | 65.3% | 0.0160 and 0.0180 ng/mL** |
PCB 156 | PCB 156 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
PCB 170 | PCB 170 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.64 | 18.2% | 0.0160 and 0.0180 ng/mL** |
PCB 180 | PCB 180 | ng/g lipid | 242 | * | * | * | <LOD | 2.66 | 4.04 | 8.43 | 59.9% | 0.0160 and 0.0180 ng/mL** |
PCB 183 | PCB 183 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
PCB 187 | PCB 187 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.29 | 11.6% | 0.0160 and 0.0180 ng/mL** |
PCB 194 | PCB 194 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.0160 and 0.0180 ng/mL** |
PCB 203 | PCB 203 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | 2.69 | 4.35 | 26.9% | 0.0173 and 0.0188 ng/mL** |
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
- Study Group Subset: Subsample 1
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
PCB 066 | PCB 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
PCB 074 | PCB 74 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
PCB 099 | PCB 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
PCB 101 | PCB 101 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
PCB 105 | PCB 105 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
PCB 118 | PCB 118 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
PCB 138 | PCB 138 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.80 | 8.3% | 0.0160 ng/mL |
PCB 153 | PCB 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 2.44 | 4.40 | 27.0% | 0.0160 ng/mL |
PCB 156 | PCB 156 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
PCB 170 | PCB 170 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
PCB 180 | PCB 180 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 3.44 | 6.90 | 44.6% | 0.0160 ng/mL |
PCB 183 | PCB 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
PCB 187 | PCB 187 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.4% | 0.0160 ng/mL |
PCB 194 | PCB 194 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
PCB 203 | PCB 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 3.08 | 18.6% | 0.0160 ng/mL |
Chemical Group: Polycyclic Aromatic Hydrocarbons (PAHs)
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
1-NAP | Naphthalene | pg/mL | 109 | 1,650 | 1,260 | 2,150 | 668 | 1,430 | 3,630 | 18,100 | 100.0% | 25 pg/mL |
1-PHEN | Phenanthrene | pg/mL | 109 | 126 | 106 | 149 | 80.2 | 133 | 259 | 478 | 99.1% | 10 pg/mL |
1-PYR | Pyrene | pg/mL | 109 | 93.0 | 75.1 | 115 | 49.3 | 88.1 | 177 | 665 | 88.1% | 20 pg/mL |
2-FLUO | Fluorene | pg/mL | 109 | 246 | 198 | 305 | 121 | 232 | 387 | 2,290 | 100.0% | 20 pg/mL |
2-NAP | Naphthalene | pg/mL | 109 | 4,290 | 3,450 | 5,340 | 1,950 | 4,190 | 10,200 | 25,000 | 100.0% | 20 pg/mL |
2-PHEN | Phenanthrene | pg/mL | 109 | 39.1 | 33.6 | 45.5 | 24.4 | 41.8 | 70.3 | 119 | 93.6% | 10 pg/mL |
3-FLUO | Fluorene | pg/mL | 109 | 124 | 97.9 | 157 | 54.2 | 103 | 227 | 1,580 | 95.4% | 20 pg/mL |
3-PHEN | Phenanthrene | pg/mL | 109 | 57.4 | 47.8 | 68.9 | 31.7 | 53.1 | 117 | 285 | 96.3% | 10 pg/mL |
9-FLUO | Fluorene | pg/mL | 109 | 323 | 268 | 389 | 184 | 312 | 607 | 1,940 | 99.1% | 37 pg/mL |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
1-NAP | Naphthalene | pg/mL | 218 | 1,230 | 873 | 1,730 | 569 | 1,060 | 2,740 | 14,700 | 98.4% | 25 pg/mL | ● |
1-NAP | Naphthalene | ng/g creatinine | 218 | 1,340 | 983 | 1,840 | 567 | 948 | 2,530 | 18,100 | 98.4% | 25 pg/mL | ● |
1-PHEN | Phenanthrene | pg/mL | 218 | 104 | 84.4 | 129 | 69.9 | 106 | 179 | 521 | 97.9% | 10 pg/mL | ● |
1-PHEN | Phenanthrene | ng/g creatinine | 218 | 114 | 95.6 | 136 | 64.4 | 107 | 164 | 427 | 97.9% | 10 pg/mL | ● |
1-PYR | Pyrene | pg/mL | 218 | 105 | 83.0 | 134 | 56.8 | 102 | 205 | 497 | 90.5% | 20 pg/mL | ● |
1-PYR | Pyrene | ng/g creatinine | 218 | 115 | 93.9 | 141 | 62.6 | 104 | 151 | 909 | 90.5% | 20 pg/mL | ● |
2-FLUO | Fluorene | pg/mL | 218 | 201 | 164 | 245 | 118 | 209 | 325 | 922 | 98.4% | 20 pg/mL | ● |
2-FLUO | Fluorene | ng/g creatinine | 218 | 219 | 185 | 260 | 127 | 178 | 299 | 1,160 | 98.4% | 20 pg/mL | ● |
2-NAP | Naphthalene | pg/mL | 218 | 3,640 | 2,990 | 4,420 | 1,780 | 3,490 | 7,940 | 19,500 | 100% | 20 pg/mL | ● |
2-NAP | Naphthalene | ng/g creatinine | 218 | 3,980 | 3,330 | 4,750 | 1,920 | 3,740 | 6,820 | 19,900 | 100% | 20 pg/mL | ● |
2-PHEN | Phenanthrene | pg/mL | 218 | 35.0 | 29.0 | 42.1 | 21.1 | 39.0 | 55.7 | 164 | 91.2% | 10 pg/mL | ● |
2-PHEN | Phenanthrene | ng/g creatinine | 218 | 38.2 | 32.5 | 44.9 | 24.3 | 34.5 | 54.6 | 134 | 91.2% | 10 pg/mL | ● |
3-FLUO | Fluorene | pg/mL | 218 | 96.3 | 74.1 | 125 | 43.9 | 90.4 | 163 | 1150 | 89.8% | 20 pg/mL | ● |
3-FLUO | Fluorene | ng/g creatinine | 218 | 105 | 83.4 | 133 | 53.2 | 82.8 | 148 | 1,140 | 89.8% | 20 pg/mL | ● |
3-PHEN | Phenanthrene | pg/mL | 218 | 56.1 | 45.5 | 69.3 | 37.2 | 57.3 | 109 | 247 | 93.3% | 10 pg/mL | ● |
3-PHEN | Phenanthrene | ng/g creatinine | 218 | 61.4 | 51.3 | 73.4 | 34.5 | 56.2 | 78.3 | 468 | 93.3% | 10 pg/mL | ● |
9-FLUO | Fluorene | pg/mL | 218 | 274 | 217 | 344 | 143 | 271 | 507 | 2140 | 96.3% | 37 pg/mL | ● |
9-FLUO | Fluorene | ng/g creatinine | 218 | 299 | 246 | 363 | 156 | 266 | 478 | 1,890 | 96.3% | 37 pg/mL | ● |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
1-NAP | Naphthalene | ng/L | 101 | 1290 | 1030 | 1610 | 613 | 1300 | 2210 | 8270 | 100% | 25.0 |
1-PHEN | Phenanthrene | ng/L | 101 | 120 | 103 | 138 | 75.0 | 119 | 196 | 455 | 100% | 10.0 |
1-PYR | Pyrene | ng/L | 101 | 87.2 | 72.8 | 105 | 50.2 | 84.2 | 141 | 457 | 95.1% | 20.0 |
2-FLUO | Fluorene | ng/L | 101 | 172 | 149 | 198 | 98.4 | 185 | 297 | 510 | 100% | 20.0 |
2-NAP | Naphthalene | ng/L | 101 | 3190 | 2690 | 3770 | 2000 | 3060 | 4830 | 11300 | 100% | 20.0 |
2-PHEN | Phenanthrene | ng/L | 101 | 67.1 | 59.5 | 75.7 | 41.1 | 64.8 | 97.9 | 204 | 100% | 10.0 |
3-FLUO | Fluorene | ng/L | 101 | 83.5 | 70.5 | 98.9 | 44.8 | 85.8 | 148 | 365 | 96.0% | 20.0 |
3-PHEN | Phenanthrene | ng/L | 101 | 88.4 | 75.7 | 103 | 51.2 | 94.1 | 140 | 367 | 100% | 10.0 |
9-FLUO | Fluorene | ng/L | 101 | 278 | 236 | 327 | 162 | 279 | 453 | 1110 | 100% | 37.0 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
1-NAP | Naphthalene | ng/L | 88 | 1020 | 800 | 1300 | 465 | 858 | 1940 | 4060 | 25.0 |
1-PHEN | Phenanthrene | ng/L | 88 | 193 | 161 | 232 | 107 | 198 | 323 | 588 | 10.0 |
1-PYR | Pyrene | ng/L | 88 | 186 | 153 | 227 | 88.2 | 211 | 334 | 598 | 20.0 |
2-FLUO | Fluorene | ng/L | 88 | 192 | 157 | 235 | 96.0 | 188 | 311 | 529 | 20.0 |
2-NAP | Naphthalene | ng/L | 88 | 6490 | 5140 | 8190 | 2780 | 6780 | 14000 | 23700 | 20.0 |
2-PHEN | Phenanthrene | ng/L | 88 | 99.4 | 85.9 | 115 | 60.6 | 94.4 | 159 | 235 | 10.0 |
3-FLUO | Fluorene | ng/L | 88 | 54.8 | 43.7 | 68.8 | 23.5 | 45.8 | 106 | 212 | 20.0 |
3-PHEN | Phenanthrene | ng/L | 88 | 69.4 | 57.3 | 84.0 | 34.1 | 70.2 | 109 | 190 | 10.0 |
9-FLUO | Fluorene | ng/L | 88 | 535 | 440 | 651 | 272 | 536 | 814 | 1370 | 37.0 |
Chemical Group: Pyrethroid Pesticides
- Measured in: Urine
Project: Biomonitoring Exposures Study (BEST) - 1.Pilot
- Study Group: 112 adults
- Sample Collection Date: -
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | µg/L | 109 | 0.774 | 0.609 | 0.983 | 0.390 | 0.736 | 1.79 | 5.95 | 98.2% | 0.0500 µg/L |
4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | µg/L | 109 | * | * | * | <LOD | <LOD | <LOD | 0.143 | 14.7% | 0.0500 µg/L |
Trans-DCCA | Cyfluthrin, cypermethrin, permethrin | µg/L | 109 | 0.614 | 0.476 | 0.792 | 0.258 | 0.555 | 1.21 | 7.42 | 98.2% | 0.0500 µg/L |
Project: Biomonitoring Exposures Study (BEST) - 2.Expanded
- Study Group: 341 adults
- Sample Collection Date:
Weighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | Notes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | ||||||||
3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | µg/L | 218 | 0.660 | 0.480 | 0.908 | 0.305 | 0.783 | 1.47 | 5.39 | 90.9% | 0.0500 µg/L | ● |
3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | µg/g creatinine | 218 | 0.722 | 0.558 | 0.934 | 0.386 | 0.747 | 1.27 | 6.41 | 90.9% | 0.0500 µg/L | ● |
4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | µg/L | 218 | * | * | * | <LOD | <LOD | <LOD | 0.224 | 19.7% | 0.0500 µg/L | ● |
4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | µg/g creatinine | 218 | * | * | * | <LOD | <LOD | <LOD | 0.230 | 19.7% | 0.0500 µg/L | ● |
Trans-DCCA | Cyfluthrin, cypermethrin, permethrin | µg/g creatinine | 218 | 0.505 | 0.383 | 0.666 | 0.221 | 0.488 | 1.15 | 6.30 | 92.6% | 0.0500 µg/L | ● |
Project: Firefighter Occupational Exposures (FOX) Project
- Study Group: 101 Firefighters
- Sample Collection Date: -
- Study Group Subset: Firefighters
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 95th | |||||||
3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | μg/L | 101 | 0.54 | 0.43 | 0.67 | 0.28 | 0.51 | 0.99 | 3.7 | 98.0% | 0.050 |
4-Fluoro-3-phenoxybenzoic acid (4F-3-PBA) | Cyfluthrin | ng/mL | 101 | * | * | * | <LOD | <LOD | <LOD | 0.063 | 10.9% | 0.050 |
Project: Maternal and Infant Environmental Exposure Project (MIEEP)
- Study Group: 92 pregnant women and their infants (65 mother-infant pairs and 27 pregnant women)
- Sample Collection Date: -
- Study Group Subset: Pregnant women
Unweighted Results
Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Limit of Detection (LOD), wet-weight | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | 25th | 50th | 75th | 90th | ||||||
3-Phenoxybenzoic acid (3-PBA) | Cyhalothrin, cypermethrin, deltamethrin, fenpropathrin, permethrin, and/or tralomethrin | μg/L | 89 | * | * | * | <LOD | <LOD | 0.46 | 2.6 | 0.40 |